|
OMIM |
Link |
Information gain |
01 |
|
PEE1
|
[NCBI]
|
0.0217559
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.00746793
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
0.00744188
|
|
|
AFP
|
[NCBI]
|
0.00573865
|
|
|
NLS
|
[NCBI]
|
0.00497531
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
0.00484112
|
|
|
PRL
|
[NCBI]
|
0.00444032
|
|
|
SRS
|
[NCBI]
|
0.00441341
|
|
|
RA
|
[NCBI]
|
0.00347823
|
|
|
DWS
|
[NCBI]
|
0.00295542
|
|
|
ACG1A
|
[NCBI]
|
0.00252016
|
|
|
dubowitz syndrome
|
[NCBI]
|
0.00225586
|
|
|
constricting bands, congenital
|
[NCBI]
|
0.00224063
|
|
|
twinning, dizygotic
|
[NCBI]
|
0.00196078
|
|
|
FRNS
|
[NCBI]
|
0.00187013
|
|
|
CPI
|
[NCBI]
|
0.00180758
|
|
|
short rib-polydactyly syndrome, type iii
|
[NCBI]
|
0.00177248
|
|
|
CRC
|
[NCBI]
|
0.00130642
|
|
|
AD
|
[NCBI]
|
0.00122187
|
|
|
renal hamartomas, nephroblastomatosis, and fetal gigantism
|
[NCBI]
|
0.00118403
|
|
|
ICP
|
[NCBI]
|
0.00111548
|
|
|
hydatidiform mole
|
[NCBI]
|
0.00111548
|
|
|
PEE2
|
[NCBI]
|
0.00109949
|
|
|
short rib-polydactyly syndrome, type iv
|
[NCBI]
|
0.00107313
|
|
|
SLE
|
[NCBI]
|
0.00105786
|
|
|
holoprosencephaly
|
[NCBI]
|
0.00103124
|
|
|
lethal congenital contracture syndrome 1
|
[NCBI]
|
0.00102825
|
|
|
PCD
|
[NCBI]
|
0.000990417
|
|
|
AMCN
|
[NCBI]
|
0.000979452
|
|
|
HFM
|
[NCBI]
|
0.000964108
|
|
|
IS1
|
[NCBI]
|
0.000951605
|
|
|
SLOS
|
[NCBI]
|
0.000902213
|
|
|
microcephalic osteodysplastic primordial dwarfism, type ii
|
[NCBI]
|
0.00088746
|
|
|
short rib-polydactyly syndrome, type i
|
[NCBI]
|
0.00088746
|
|
|
anencephaly
|
[NCBI]
|
0.000827851
|
|
|
intestinal atresia, multiple
|
[NCBI]
|
0.000779645
|
|
|
EPV
|
[NCBI]
|
0.000745274
|
|
|
pyloric atresia
|
[NCBI]
|
0.000745274
|
|
|
patent ductus arteriosus
|
[NCBI]
|
0.000745274
|
|
|
MKS1
|
[NCBI]
|
0.000654376
|
|
|
multiple pterygium syndrome, lethal type
|
[NCBI]
|
0.000611271
|
|
|
campomelia, cumming type
|
[NCBI]
|
0.000591265
|
|
|
SCAR2
|
[NCBI]
|
0.000591265
|
|
|
PAEP
|
[NCBI]
|
0.00057059
|
|
|
TD1
|
[NCBI]
|
0.000563785
|
|
|
microcephalic osteodysplastic primordial dwarfism, type i
|
[NCBI]
|
0.000558777
|
|
|
cardiomyopathy, fatal fetal, due to myocardial calcification
|
[NCBI]
|
0.000549535
|
|
|
vertebral ossification, defect in, with nephrogenic rests
|
[NCBI]
|
0.000549535
|
|
|
ventriculomegaly with defects of the radius and kidney
|
[NCBI]
|
0.000549535
|
|
|
succinic acidemia
|
[NCBI]
|
0.000549535
|
|
|
polyneuropathy, lethal neonatal, axonal sensorimotor, autosomal recessive
|
[NCBI]
|
0.000549535
|
|
|
amobarbital, deficient n-hydroxylation of
|
[NCBI]
|
0.000549535
|
|
|
PEE3
|
[NCBI]
|
0.000549535
|
|
|
theophylline biotransformation
|
[NCBI]
|
0.000549535
|
|
|
metatarsus varus, type i
|
[NCBI]
|
0.000549535
|
|
|
aphalangia, partial, with syndactyly and duplication of metatarsal iv
|
[NCBI]
|
0.000549535
|
|
|
pontocerebellar hypoplasia, type 1
|
[NCBI]
|
0.000549535
|
|
|
immunoneurologic disorder, x-linked
|
[NCBI]
|
0.000549535
|
|
|
TFPI2
|
[NCBI]
|
0.000547714
|
|
|
CJD
|
[NCBI]
|
0.000542167
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000523282
|
|
|
MDD
|
[NCBI]
|
0.000521134
|
|
|
KLK3
|
[NCBI]
|
0.00050245
|
|
|
RTD
|
[NCBI]
|
0.000491206
|
|
|
FSHMD1A
|
[NCBI]
|
0.000476523
|
|
|
BWS
|
[NCBI]
|
0.000466953
|
|
|
valproate embryopathy, susceptibility to
|
[NCBI]
|
0.000459066
|
|
|
short rib-polydactyly syndrome, type ii
|
[NCBI]
|
0.000458631
|
|
|
chondrodysplasia punctata, autosomal dominant
|
[NCBI]
|
0.000432619
|
|
|
fraser syndrome
|
[NCBI]
|
0.000424519
|
|
|
ST8
|
[NCBI]
|
0.00041718
|
|
|
megacystis-microcolon-intestinal hypoperistalsis syndrome
|
[NCBI]
|
0.00041718
|
|
|
HSAS
|
[NCBI]
|
0.000416433
|
|
|
dysgnathia complex
|
[NCBI]
|
0.000413267
|
|
|
APC
|
[NCBI]
|
0.000413206
|
|
|
PZP
|
[NCBI]
|
0.000408919
|
|
|
diaphragmatic hernia, congenital
|
[NCBI]
|
0.000404231
|
|
|
SERPINA6
|
[NCBI]
|
0.000403373
|
|
|
CRH
|
[NCBI]
|
0.000402956
|
|
|
omodysplasia, generalized form
|
[NCBI]
|
0.000353818
|
|
|
progeroid syndrome, neonatal
|
[NCBI]
|
0.000353818
|
|
|
achalasia, familial esophageal
|
[NCBI]
|
0.000353818
|
|
|
AMC
|
[NCBI]
|
0.000352251
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
0.00032376
|
|
|
PD
|
[NCBI]
|
0.000313634
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
0.000308639
|
|
|
AVSD
|
[NCBI]
|
0.000306136
|
|
|
THAS
|
[NCBI]
|
0.000305468
|
|
|
stomatocytosis ii
|
[NCBI]
|
0.000295445
|
|
|
hypertelorism, microtia, facial clefting syndrome
|
[NCBI]
|
0.000295445
|
|
|
hypercalciuria, absorptive, 1
|
[NCBI]
|
0.000295445
|
|
|
thrombocytopenia, autosomal recessive
|
[NCBI]
|
0.000295445
|
|
|
pontocerebellar hypoplasia, type 2
|
[NCBI]
|
0.000295445
|
|
|
protrusio acetabuli
|
[NCBI]
|
0.000295445
|
|
|
genitopatellar syndrome
|
[NCBI]
|
0.000295445
|
|
|
auriculocondylar syndrome
|
[NCBI]
|
0.000295445
|
|
|
MRX50
|
[NCBI]
|
0.000295445
|
|
|
heart block, congenital
|
[NCBI]
|
0.000283943
|
|
|
EFE
|
[NCBI]
|
0.000283773
|
|
|
IDDM
|
[NCBI]
|
0.00026589
|
|
|
ATD1
|
[NCBI]
|
0.000264609
|
|
|
DHS
|
[NCBI]
|
0.000264609
|
|
|
isotretinoin embryopathy-like syndrome
|
[NCBI]
|
0.000262281
|
|
|
gracile bone dysplasia
|
[NCBI]
|
0.000262281
|
|
|
chondrodysplasia punctata, tibia-metacarpal type
|
[NCBI]
|
0.000262281
|
|
|
RP
|
[NCBI]
|
0.000258741
|
|
|
hydrolethalus syndrome 1
|
[NCBI]
|
0.000245484
|
|
|
EGFR
|
[NCBI]
|
0.00024527
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
0.000241335
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000232764
|
|
|
PCA
|
[NCBI]
|
0.000231012
|
|
|
ABS
|
[NCBI]
|
0.00022658
|
|
|
PKS
|
[NCBI]
|
0.000221426
|
|
|
JBTS1
|
[NCBI]
|
0.000220981
|
|
|
thrombocytopenia-absent radius syndrome
|
[NCBI]
|
0.000220981
|
|
|
ALPP
|
[NCBI]
|
0.000219321
|
|
|
MPO
|
[NCBI]
|
0.000209127
|
|
|
thyroid hormonogenesis, genetic defect in, 3
|
[NCBI]
|
0.000206469
|
|
|
telangiectasia, hereditary benign
|
[NCBI]
|
0.000206469
|
|
|
cerebellar atrophy with progressive microcephaly
|
[NCBI]
|
0.000206469
|
|
|
faciodigitogenital syndrome, recessive
|
[NCBI]
|
0.000206469
|
|
|
dyssegmental dysplasia, rolland-desbuquois type
|
[NCBI]
|
0.000206469
|
|
|
renal-hepatic-pancreatic dysplasia with dandy-walker cyst
|
[NCBI]
|
0.000206469
|
|
|
CND
|
[NCBI]
|
0.000206469
|
|
|
pelvic organ prolapse
|
[NCBI]
|
0.000206469
|
|
|
acromelic frontonasal dysostosis
|
[NCBI]
|
0.000206469
|
|
|
microcephalic osteodysplastic primordial dwarfism, type iii
|
[NCBI]
|
0.000206469
|
|
|
bone size quantitative trait locus 1
|
[NCBI]
|
0.000206469
|
|
|
valinemia
|
[NCBI]
|
0.000206469
|
|
|
hypoadrenocorticism, familial
|
[NCBI]
|
0.000206469
|
|
|
omodysplasia
|
[NCBI]
|
0.000206469
|
|
|
d-glyceric acidemia
|
[NCBI]
|
0.000206469
|
|
|
arima syndrome
|
[NCBI]
|
0.000206469
|
|
|
trichohepatoenteric syndrome
|
[NCBI]
|
0.000206469
|
|
|
bullous dystrophy, hereditary macular type
|
[NCBI]
|
0.000206469
|
|
|
adducted thumb-clubfoot syndrome
|
[NCBI]
|
0.000206469
|
|
|
TNF
|
[NCBI]
|
0.000202162
|
|
|
dandy-walker-like malformation with atrioventricular septal defect
|
[NCBI]
|
0.000201662
|
|
|
propionic acidemia
|
[NCBI]
|
0.000198167
|
|
|
PPROM
|
[NCBI]
|
0.0001967
|
|
|
camptomelic syndrome, long-limb type
|
[NCBI]
|
0.0001967
|
|
|
fetal akinesia syndrome, x-linked
|
[NCBI]
|
0.0001967
|
|
|
PEE4
|
[NCBI]
|
0.0001967
|
|
|
uterine anomalies
|
[NCBI]
|
0.0001967
|
|
|
mullerian aplasia
|
[NCBI]
|
0.0001967
|
|
|
ovarian hyperstimulation syndrome
|
[NCBI]
|
0.0001967
|
|
|
aprosencephaly syndrome
|
[NCBI]
|
0.0001967
|
|
|
diastrophic dysplasia
|
[NCBI]
|
0.000188269
|
|
|
PTHLH
|
[NCBI]
|
0.000177239
|
|
|
poland syndrome
|
[NCBI]
|
0.000176198
|
|
|
walker-warburg syndrome
|
[NCBI]
|
0.0001686
|
|
|
EEC1
|
[NCBI]
|
0.000167875
|
|
|
APOE
|
[NCBI]
|
0.000162598
|
|
|
CCK
|
[NCBI]
|
0.000160533
|
|
|
MRD
|
[NCBI]
|
0.000153937
|
|
|
CDPX1
|
[NCBI]
|
0.000153351
|
|
|
klippel-feil syndrome, autosomal dominant
|
[NCBI]
|
0.000152592
|
|
|
EXT3
|
[NCBI]
|
0.000152592
|
|
|
oculocerebral syndrome with hypopigmentation
|
[NCBI]
|
0.000152592
|
|
|
antipyrine metabolism
|
[NCBI]
|
0.000152592
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.000152592
|
|
|
dandy-walker malformation with mental retardation, basal ganglia disease, and seizures
|
[NCBI]
|
0.000152592
|
|
|
fibrochondrogenesis
|
[NCBI]
|
0.000152592
|
|
|
DFNB15
|
[NCBI]
|
0.000152592
|
|
|
nipples, supernumerary
|
[NCBI]
|
0.000152592
|
|
|
trichorrhexis nodosa syndrome
|
[NCBI]
|
0.000152592
|
|
|
OSCS
|
[NCBI]
|
0.000152592
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
0.000152592
|
|
|
peeling skin syndrome
|
[NCBI]
|
0.000152592
|
|
|
sneddon syndrome
|
[NCBI]
|
0.000152592
|
|
|
prosopagnosia, hereditary
|
[NCBI]
|
0.000152592
|
|
|
fatty metamorphosis of viscera
|
[NCBI]
|
0.000152592
|
|
|
microphthalmia with limb anomalies
|
[NCBI]
|
0.000152592
|
|
|
CHDM
|
[NCBI]
|
0.000152592
|
|
|
carbimazole sensitivity
|
[NCBI]
|
0.000152409
|
|
|
chylothorax, congenital
|
[NCBI]
|
0.000152409
|
|
|
COFS1
|
[NCBI]
|
0.00015202
|
|
|
EGF
|
[NCBI]
|
0.000150869
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
0.000150311
|
|
|
GNRH1
|
[NCBI]
|
0.000149643
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
0.000147566
|
|
|
AVP
|
[NCBI]
|
0.000147557
|
|
|
phenylketonuria
|
[NCBI]
|
0.000147519
|
|
|
RBS
|
[NCBI]
|
0.00014586
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
0.000142281
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
0.000142281
|
|
|
DMD
|
[NCBI]
|
0.000139106
|
|
|
DHFR
|
[NCBI]
|
0.000136208
|
|
|
coffin-siris syndrome
|
[NCBI]
|
0.000134363
|
|
|
hydrops fetalis, idiopathic
|
[NCBI]
|
0.000131126
|
|
|
brachial amelia, forebrain defects, and facial clefts
|
[NCBI]
|
0.000131126
|
|
|
craniomicromelic syndrome
|
[NCBI]
|
0.000131126
|
|
|
chondrodysplasia punctata, brachytelephalangic, autosomal
|
[NCBI]
|
0.000131126
|
|
|
prolactin deficiency, isolated
|
[NCBI]
|
0.000131126
|
|
|
amenorrhea-galactorrhea syndrome
|
[NCBI]
|
0.000131126
|
|
|
murcs association
|
[NCBI]
|
0.000131126
|
|
|
polyhydramnios, chronic idiopathic
|
[NCBI]
|
0.000131126
|
|
|
schneckenbecken dysplasia
|
[NCBI]
|
0.00013083
|
|
|
FFS
|
[NCBI]
|
0.00013083
|
|
|
GACI
|
[NCBI]
|
0.00013082
|
|
|
temporal arteritis
|
[NCBI]
|
0.000129973
|
|
|
krabbe disease
|
[NCBI]
|
0.000129273
|
|
|
MFS
|
[NCBI]
|
0.000120468
|
|
|
MJD
|
[NCBI]
|
0.000116297
|
|
|
boomerang dysplasia
|
[NCBI]
|
0.0001157
|
|
|
oeis complex
|
[NCBI]
|
0.0001157
|
|
|
EHBA
|
[NCBI]
|
0.0001157
|
|
|
tight skin contracture syndrome, lethal
|
[NCBI]
|
0.000115441
|
|
|
glutathione synthetase deficiency
|
[NCBI]
|
0.000115441
|
|
|
spinal muscular atrophy, childhood, proximal, autosomal dominant
|
[NCBI]
|
0.000115384
|
|
|
BZX
|
[NCBI]
|
0.000115384
|
|
|
tongue, pigmented fungiform papillae of
|
[NCBI]
|
0.000115384
|
|
|
hemifacial microsomia with radial defects
|
[NCBI]
|
0.000115384
|
|
|
ehlers-danlos syndrome, type vib
|
[NCBI]
|
0.000115384
|
|
|
chorioretinal dystrophy, spinocerebellar ataxia, and hypogonadotropic hypogonadism
|
[NCBI]
|
0.000115384
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
0.000114359
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.000110966
|
|
|
multiple pterygium syndrome, escobar variant
|
[NCBI]
|
0.000108482
|
|
|
VDR
|
[NCBI]
|
0.000107943
|
|
|
WHS
|
[NCBI]
|
0.000107598
|
|
|
CDLS1
|
[NCBI]
|
0.000107598
|
|
|
CSH1
|
[NCBI]
|
0.000107478
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
0.000104784
|
|
|
MCOPS9
|
[NCBI]
|
0.000104023
|
|
|
PAPPA
|
[NCBI]
|
0.000103722
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.000103258
|
|
|
RNASE3
|
[NCBI]
|
0.000102946
|
|
|
EKD1
|
[NCBI]
|
0.000102911
|
|
|
niemann-pick disease, type b
|
[NCBI]
|
0.000102211
|
|
|
ACH
|
[NCBI]
|
0.000101832
|
|
|
GTS
|
[NCBI]
|
9.73588e-05
|
|
|
ichthyosis congenita, harlequin fetus type
|
[NCBI]
|
9.65141e-05
|
|
|
AOI
|
[NCBI]
|
9.45356e-05
|
|
|
vacterl association with hydrocephalus, x-linked
|
[NCBI]
|
9.45356e-05
|
|
|
AMH
|
[NCBI]
|
9.36728e-05
|
|
|
spondylocostal dysostosis with anal atresia and urogenital anomalies
|
[NCBI]
|
9.36434e-05
|
|
|
tracheobronchial stenosis, congenital
|
[NCBI]
|
9.36434e-05
|
|
|
CFTR
|
[NCBI]
|
9.35434e-05
|
|
|
ZS
|
[NCBI]
|
9.03107e-05
|
|
|
CD
|
[NCBI]
|
8.96568e-05
|
|
|
cayler cardiofacial syndrome
|
[NCBI]
|
8.81504e-05
|
|
|
geleophysic dysplasia
|
[NCBI]
|
8.79949e-05
|
|
|
OSCS
|
[NCBI]
|
8.79949e-05
|
|
|
MKS2
|
[NCBI]
|
8.79949e-05
|
|
|
branchial clefts with characteristic facies, growth retardation, imperforate nasolacrimal duct, and premature aging
|
[NCBI]
|
8.79949e-05
|
|
|
peho syndrome
|
[NCBI]
|
8.79949e-05
|
|
|
immunoglobulin m, level of
|
[NCBI]
|
8.79949e-05
|
|
|
microtia-anotia
|
[NCBI]
|
8.79949e-05
|
|
|
hypertrichotic osteochondrodysplasia
|
[NCBI]
|
8.79949e-05
|
|
|
tibia, hypoplasia of, with polydactyly
|
[NCBI]
|
8.79949e-05
|
|
|
CYP1A1
|
[NCBI]
|
8.77219e-05
|
|
|
BOCD
|
[NCBI]
|
8.65719e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
8.65719e-05
|
|
|
ACG2
|
[NCBI]
|
8.65719e-05
|
|
|
MKKS
|
[NCBI]
|
8.65137e-05
|
|
|
INSL4
|
[NCBI]
|
8.64181e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
8.56845e-05
|
|
|
DGS
|
[NCBI]
|
8.30211e-05
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
8.18854e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
8.17597e-05
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
7.97323e-05
|
|
|
pseudotrisomy 13 syndrome
|
[NCBI]
|
7.97323e-05
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
7.97323e-05
|
|
|
PCS
|
[NCBI]
|
7.97323e-05
|
|
|
hydrocephalus
|
[NCBI]
|
7.97323e-05
|
|
|
SXI1
|
[NCBI]
|
7.97323e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
7.96574e-05
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
7.79775e-05
|
|
|
SHFM1
|
[NCBI]
|
7.7559e-05
|
|
|
bartter syndrome, antenatal, type 1
|
[NCBI]
|
7.71266e-05
|
|
|
yellow nail syndrome
|
[NCBI]
|
7.71266e-05
|
|
|
FIDD
|
[NCBI]
|
7.71266e-05
|
|
|
weyers ulnar ray/oligodactyly syndrome
|
[NCBI]
|
7.71266e-05
|
|
|
atrioventricular conduction time
|
[NCBI]
|
7.71266e-05
|
|
|
nuchal bleb, familial
|
[NCBI]
|
7.71266e-05
|
|
|
polydactyly, preaxial i
|
[NCBI]
|
7.71266e-05
|
|
|
MBS
|
[NCBI]
|
7.60498e-05
|
|
|
LNPEP
|
[NCBI]
|
7.53943e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
7.41505e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
7.41505e-05
|
|
|
PGF
|
[NCBI]
|
7.34333e-05
|
|
|
PRLR
|
[NCBI]
|
7.33748e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
7.32986e-05
|
|
|
PCNA
|
[NCBI]
|
7.29298e-05
|
|
|
PCOS1
|
[NCBI]
|
7.15482e-05
|
|
|
TSD
|
[NCBI]
|
7.0453e-05
|
|
|
RLN1
|
[NCBI]
|
6.90332e-05
|
|
|
abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism
|
[NCBI]
|
6.84702e-05
|
|
|
CGB
|
[NCBI]
|
6.79845e-05
|
|
|
PSG1
|
[NCBI]
|
6.79623e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
6.74191e-05
|
|
|
maxillonasal dysplasia, binder type
|
[NCBI]
|
6.70947e-05
|
|
|
diarrhea 2, with microvillous atrophy
|
[NCBI]
|
6.70947e-05
|
|
|
beta-aminoisobutyric acid, urinary excretion of
|
[NCBI]
|
6.70947e-05
|
|
|
acetabular dysplasia
|
[NCBI]
|
6.70947e-05
|
|
|
acrodysostosis
|
[NCBI]
|
6.70947e-05
|
|
|
NYS2
|
[NCBI]
|
6.70947e-05
|
|
|
popliteal pterygium syndrome, lethal type
|
[NCBI]
|
6.70947e-05
|
|
|
TAPVR1
|
[NCBI]
|
6.70947e-05
|
|
|
FSHR
|
[NCBI]
|
6.70388e-05
|
|
|
AT
|
[NCBI]
|
6.61158e-05
|
|
|
follicle-stimulating hormone deficiency, isolated
|
[NCBI]
|
6.60308e-05
|
|
|
ablepharon-macrostomia syndrome
|
[NCBI]
|
6.60308e-05
|
|
|
HCH
|
[NCBI]
|
6.58549e-05
|
|
|
brain anomalies, retardation, ectodermal dysplasia, skeletal malformations, hirschsprung disease, ear/eye anomalies, cleft palate/cryptorchidism, and kidney dysplasia/hypoplasia
|
[NCBI]
|
6.55596e-05
|
|
|
preaxial hallucal polydactyly
|
[NCBI]
|
6.55596e-05
|
|
|
craniotelencephalic dysplasia
|
[NCBI]
|
6.55596e-05
|
|
|
fryns microphthalmia syndrome
|
[NCBI]
|
6.55596e-05
|
|
|
vascular helix of umbilical cord
|
[NCBI]
|
6.55596e-05
|
|
|
B1G2
|
[NCBI]
|
6.55596e-05
|
|
|
furlong syndrome: fs
|
[NCBI]
|
6.55596e-05
|
|
|
osteosclerotic chondrodysplasia, lethal, with intracellular inclusions
|
[NCBI]
|
6.55596e-05
|
|
|
aprosencephaly and cerebellar dysgenesis
|
[NCBI]
|
6.55596e-05
|
|
|
convulsive disorder, familial, with prenatal or early onset
|
[NCBI]
|
6.55596e-05
|
|
|
palmomental reflex
|
[NCBI]
|
6.55596e-05
|
|
|
hydrocephalus with associated malformations
|
[NCBI]
|
6.55596e-05
|
|
|
JBTS6
|
[NCBI]
|
6.55596e-05
|
|
|
gms syndrome
|
[NCBI]
|
6.55596e-05
|
|
|
cystic kidney disease with ventriculomegaly
|
[NCBI]
|
6.55596e-05
|
|
|
lipomyelomeningocele
|
[NCBI]
|
6.55596e-05
|
|
|
PMSE
|
[NCBI]
|
6.55596e-05
|
|
|
adenomyosis
|
[NCBI]
|
6.55596e-05
|
|
|
proteolytic capacity of plasma
|
[NCBI]
|
6.55596e-05
|
|
|
encephalopathy, fatal infantile, with olivopontocerebellar hypoplasia
|
[NCBI]
|
6.55596e-05
|
|
|
osteogenesis imperfecta, sillence type ii/iii, without abnormality of type i collagen
|
[NCBI]
|
6.55596e-05
|
|
|
pyknoachondrogenesis
|
[NCBI]
|
6.55596e-05
|
|
|
radius, aplasia of, with cleft lip/palate
|
[NCBI]
|
6.55596e-05
|
|
|
kniest-like dysplasia, lethal
|
[NCBI]
|
6.55596e-05
|
|
|
myoclonus, cerebellar ataxia, and deafness
|
[NCBI]
|
6.55596e-05
|
|
|
laryngomalacia
|
[NCBI]
|
6.55596e-05
|
|
|
microcephaly, congenital heart disease, unilateral renal agenesis, and hyposegmented lungs
|
[NCBI]
|
6.55596e-05
|
|
|
CLE
|
[NCBI]
|
6.55596e-05
|
|
|
crane-heise syndrome
|
[NCBI]
|
6.55596e-05
|
|
|
craniodiaphyseal dysplasia, dominant
|
[NCBI]
|
6.55596e-05
|
|
|
renal tubulopathy, diabetes mellitus, and cerebellar ataxia due to duplication of mitochondrial dna
|
[NCBI]
|
6.55596e-05
|
|
|
porencephaly, cerebellar hypoplasia, and internal malformations
|
[NCBI]
|
6.55596e-05
|
|
|
chondrodysplasia, lethal, with long bone angulation and mixed bone density
|
[NCBI]
|
6.55596e-05
|
|
|
brachioskeletogenital syndrome
|
[NCBI]
|
6.55596e-05
|
|
|
PUPPP
|
[NCBI]
|
6.55596e-05
|
|
|
ureterocele
|
[NCBI]
|
6.55596e-05
|
|
|
lethal short-limb skeletal dysplasia, al gazali type
|
[NCBI]
|
6.55596e-05
|
|
|
acid phosphatase deficiency
|
[NCBI]
|
6.55596e-05
|
|
|
twinning due to superfetation
|
[NCBI]
|
6.55596e-05
|
|
|
finger locking, recurrent, with intrauterine growth retardation and proportionate short stature
|
[NCBI]
|
6.55596e-05
|
|
|
ectrodactyly-polydactyly
|
[NCBI]
|
6.55596e-05
|
|
|
fibuloulnar aplasia or hypoplasia with renal abnormalities
|
[NCBI]
|
6.55596e-05
|
|
|
COFS2
|
[NCBI]
|
6.55596e-05
|
|
|
aortic arch interruption, facial palsy, and retinal coloboma
|
[NCBI]
|
6.55596e-05
|
|
|
splenogonadal fusion with limb defects and micrognathia
|
[NCBI]
|
6.55596e-05
|
|
|
lip prints
|
[NCBI]
|
6.55596e-05
|
|
|
cleft-limb-heart malformation syndrome
|
[NCBI]
|
6.55596e-05
|
|
|
phosphatase, acid, of tissues
|
[NCBI]
|
6.55596e-05
|
|
|
hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy
|
[NCBI]
|
6.55596e-05
|
|
|
amelia, autosomal recessive
|
[NCBI]
|
6.55596e-05
|
|
|
SEMA4C
|
[NCBI]
|
6.55596e-05
|
|
|
cleft lip, congenital healed
|
[NCBI]
|
6.55596e-05
|
|
|
ulnar hypoplasia with mental retardation
|
[NCBI]
|
6.55596e-05
|
|
|
ectodermal dysplasia with natal teeth, turnpenny type
|
[NCBI]
|
6.55596e-05
|
|
|
osteopetrosis and infantile neuroaxonal dystrophy
|
[NCBI]
|
6.55596e-05
|
|
|
hirschsprung disease with ulnar polydactyly, polysyndactyly of big toes, and ventricular septal defect
|
[NCBI]
|
6.55596e-05
|
|
|
pulmonary atresia with intact ventricular septum
|
[NCBI]
|
6.55596e-05
|
|
|
bone fragility with craniosynostosis, ocular proptosis, hydrocephalus, and distinctive facial features
|
[NCBI]
|
6.55596e-05
|
|
|
MLRD
|
[NCBI]
|
6.55596e-05
|
|
|
tibia, absence or hypoplasia of, with polydactyly, retrocerebellar arachnoid cyst, and other anomalies
|
[NCBI]
|
6.55596e-05
|
|
|
somatomedin, embryonic
|
[NCBI]
|
6.55596e-05
|
|
|
diaphragmatic defects, limb deficiencies, and ossification defects of skull
|
[NCBI]
|
6.55596e-05
|
|
|
camptodactyly syndrome, guadalajara type ii
|
[NCBI]
|
6.55596e-05
|
|
|
split-hand with obstructive uropathy, spina bifida, and diaphragmatic defects
|
[NCBI]
|
6.55596e-05
|
|
|
galactorrhea
|
[NCBI]
|
6.55596e-05
|
|
|
thoracic dysplasia-hydrocephalus syndrome
|
[NCBI]
|
6.55596e-05
|
|
|
subependymoma
|
[NCBI]
|
6.55596e-05
|
|
|
microcephaly, severe, with skeletal anomalies including posterior rib-gap defects
|
[NCBI]
|
6.55596e-05
|
|
|
blood group--en
|
[NCBI]
|
6.55596e-05
|
|
|
situs inversus totalis with cystic dysplasia of kidneys and pancreas
|
[NCBI]
|
6.55596e-05
|
|
|
polysyndactyly with cardiac malformation
|
[NCBI]
|
6.55596e-05
|
|
|
radioulnar synostosis, radial ray abnormalities, and severe malformations in the male
|
[NCBI]
|
6.55596e-05
|
|
|
metaphyseal modeling abnormality, skin lesions, and spastic paraplegia
|
[NCBI]
|
6.55596e-05
|
|
|
phaver syndrome
|
[NCBI]
|
6.55596e-05
|
|
|
spondyloepiphyseal dysplasia with atlantoaxial instability
|
[NCBI]
|
6.55596e-05
|
|
|
baby rattle pelvis dysplasia
|
[NCBI]
|
6.55596e-05
|
|
|
fibular aplasia, tibial campomelia, and oligosyndactyly syndrome
|
[NCBI]
|
6.55596e-05
|
|
|
ABP1
|
[NCBI]
|
6.54139e-05
|
|
|
HPGD
|
[NCBI]
|
6.52345e-05
|
|
|
CVID
|
[NCBI]
|
6.47296e-05
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
6.3742e-05
|
|
|
argininosuccinic aciduria
|
[NCBI]
|
6.3742e-05
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
6.3742e-05
|
|
|
cutis laxa, autosomal recessive, type ii
|
[NCBI]
|
6.3742e-05
|
|
|
NCIE1
|
[NCBI]
|
6.3742e-05
|
|
|
sacral defect with anterior meningocele
|
[NCBI]
|
6.3742e-05
|
|
|
EPHX1
|
[NCBI]
|
6.3584e-05
|
|
|
campomelic dysplasia
|
[NCBI]
|
6.34914e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
6.29201e-05
|
|
|
sickle cell anemia
|
[NCBI]
|
6.17383e-05
|
|
|
APOB
|
[NCBI]
|
6.1275e-05
|
|
|
SRF
|
[NCBI]
|
6.0377e-05
|
|
|
STOX1
|
[NCBI]
|
5.99309e-05
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
5.89667e-05
|
|
|
RTT
|
[NCBI]
|
5.83386e-05
|
|
|
FDH
|
[NCBI]
|
5.83109e-05
|
|
|
MB
|
[NCBI]
|
5.81566e-05
|
|
|
gastroschisis
|
[NCBI]
|
5.77086e-05
|
|
|
PLSDT
|
[NCBI]
|
5.77086e-05
|
|
|
NLRP7
|
[NCBI]
|
5.76095e-05
|
|
|
autism
|
[NCBI]
|
5.7533e-05
|
|
|
CTNS
|
[NCBI]
|
5.69515e-05
|
|
|
ARPKD
|
[NCBI]
|
5.64538e-05
|
|
|
ALPI
|
[NCBI]
|
5.60614e-05
|
|
|
VUR1
|
[NCBI]
|
5.57013e-05
|
|
|
glutaric acidemia i
|
[NCBI]
|
5.56053e-05
|
|
|
STAR
|
[NCBI]
|
5.34862e-05
|
|
|
GHR
|
[NCBI]
|
5.34281e-05
|
|
|
EVC
|
[NCBI]
|
5.31607e-05
|
|
|
TH
|
[NCBI]
|
5.24866e-05
|
|
|
FABP3
|
[NCBI]
|
5.22759e-05
|
|
|
pitt syndrome
|
[NCBI]
|
5.20677e-05
|
|
|
GCE
|
[NCBI]
|
5.20677e-05
|
|
|
seckel syndrome 1
|
[NCBI]
|
5.20677e-05
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
5.20677e-05
|
|
|
SHBG
|
[NCBI]
|
5.16727e-05
|
|
|
sulfocysteinuria
|
[NCBI]
|
5.10939e-05
|
|
|
vater association
|
[NCBI]
|
5.10939e-05
|
|
|
TD2
|
[NCBI]
|
5.10939e-05
|
|
|
three m syndrome
|
[NCBI]
|
5.10939e-05
|
|
|
pancreas, annular
|
[NCBI]
|
5.10939e-05
|
|
|
AOII
|
[NCBI]
|
5.10939e-05
|
|
|
hemochromatosis, neonatal
|
[NCBI]
|
5.10939e-05
|
|
|
NPY
|
[NCBI]
|
5.1062e-05
|
|
|
iminoglycinuria
|
[NCBI]
|
5.08067e-05
|
|
|
carnitine deficiency, myopathic
|
[NCBI]
|
5.08067e-05
|
|
|
ANON1
|
[NCBI]
|
5.08067e-05
|
|
|
strabismus, susceptibility to
|
[NCBI]
|
5.08067e-05
|
|
|
gastroesophageal reflux
|
[NCBI]
|
5.08067e-05
|
|
|
skin creases, multiple benign ring-shaped, of limbs
|
[NCBI]
|
5.08067e-05
|
|
|
robinow syndrome, autosomal dominant
|
[NCBI]
|
5.08067e-05
|
|
|
GO
|
[NCBI]
|
5.08067e-05
|
|
|
EIG
|
[NCBI]
|
5.05557e-05
|
|
|
PTK2
|
[NCBI]
|
5.01404e-05
|
|
|
VEGF
|
[NCBI]
|
5.00613e-05
|
|
|
HSAN3
|
[NCBI]
|
4.93346e-05
|
|
|
kabuki syndrome
|
[NCBI]
|
4.90431e-05
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
4.88197e-05
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
4.88197e-05
|
|
|
HPS
|
[NCBI]
|
4.80621e-05
|
|
|
NOS3
|
[NCBI]
|
4.69538e-05
|
|
|
alkaline phosphatase, intestinal, fetal form
|
[NCBI]
|
4.67595e-05
|
|
|
LGALS13
|
[NCBI]
|
4.67595e-05
|
|
|
PYY
|
[NCBI]
|
4.66792e-05
|
|
|
BGS
|
[NCBI]
|
4.58248e-05
|
|
|
TCOF
|
[NCBI]
|
4.57989e-05
|
|
|
antiphospholipid syndrome
|
[NCBI]
|
4.56413e-05
|
|
|
omphalocele
|
[NCBI]
|
4.56413e-05
|
|
|
DLK1
|
[NCBI]
|
4.49106e-05
|
|
|
ALPL
|
[NCBI]
|
4.38715e-05
|
|
|
ANXA5
|
[NCBI]
|
4.33671e-05
|
|
|
VIP
|
[NCBI]
|
4.31612e-05
|
|
|
CLN2
|
[NCBI]
|
4.3053e-05
|
|
|
CBAVD
|
[NCBI]
|
4.3053e-05
|
|
|
SOD2
|
[NCBI]
|
4.28575e-05
|
|
|
INSL3
|
[NCBI]
|
4.2012e-05
|
|
|
GRHL3
|
[NCBI]
|
4.11335e-05
|
|
|
OXTR
|
[NCBI]
|
4.11335e-05
|
|
|
por deficiency
|
[NCBI]
|
4.10327e-05
|
|
|
caffey disease
|
[NCBI]
|
4.10327e-05
|
|
|
3-@methylglutaconic aciduria, type i
|
[NCBI]
|
4.10327e-05
|
|
|
RASA1
|
[NCBI]
|
4.03949e-05
|
|
|
OXT
|
[NCBI]
|
4.0157e-05
|
|
|
PNCK
|
[NCBI]
|
3.99533e-05
|
|
|
SMPX
|
[NCBI]
|
3.99533e-05
|
|
|
galactosemia
|
[NCBI]
|
3.97943e-05
|
|
|
TP53
|
[NCBI]
|
3.97441e-05
|
|
|
acrofacial dysostosis, catania type
|
[NCBI]
|
3.85601e-05
|
|
|
renal dysplasia, diffuse cystic
|
[NCBI]
|
3.85601e-05
|
|
|
MKS4
|
[NCBI]
|
3.85601e-05
|
|
|
teeth present at birth
|
[NCBI]
|
3.85601e-05
|
|
|
aarskog syndrome
|
[NCBI]
|
3.85601e-05
|
|
|
oroacral syndrome, verloes-koulischer type
|
[NCBI]
|
3.85601e-05
|
|
|
thanatophoric dysplasia, glasgow variant
|
[NCBI]
|
3.85601e-05
|
|
|
MCOPCB4
|
[NCBI]
|
3.85601e-05
|
|
|
hypophosphatasia, childhood
|
[NCBI]
|
3.85601e-05
|
|
|
pulmonary hypoplasia, primary
|
[NCBI]
|
3.85601e-05
|
|
|
cardiomyopathy-hypogonadism-collagenoma syndrome
|
[NCBI]
|
3.85601e-05
|
|
|
t-cell immunodeficiency, congenital alopecia, and nail dystrophy
|
[NCBI]
|
3.85601e-05
|
|
|
BDA6
|
[NCBI]
|
3.85601e-05
|
|
|
enterocolitis
|
[NCBI]
|
3.85601e-05
|
|
|
neuronal intranuclear inclusion disease
|
[NCBI]
|
3.85601e-05
|
|
|
hypercalcemia, idiopathic, of infancy
|
[NCBI]
|
3.85601e-05
|
|
|
hernia, anterior diaphragmatic
|
[NCBI]
|
3.85601e-05
|
|
|
contractures, congenital, torticollis, and malignant hyperthermia
|
[NCBI]
|
3.85601e-05
|
|
|
dandy-walker malformation with postaxial polydactyly
|
[NCBI]
|
3.85601e-05
|
|
|
lowry-maclean syndrome
|
[NCBI]
|
3.85601e-05
|
|
|
secretory component deficiency
|
[NCBI]
|
3.85601e-05
|
|
|
chondrodysplasia punctata syndrome
|
[NCBI]
|
3.85601e-05
|
|
|
cutis gyrata syndrome of beare and stevenson
|
[NCBI]
|
3.85601e-05
|
|
|
acrorenal-mandibular syndrome
|
[NCBI]
|
3.85601e-05
|
|
|
waardenburg syndrome, type iid
|
[NCBI]
|
3.85601e-05
|
|
|
cahmr syndrome
|
[NCBI]
|
3.85601e-05
|
|
|
cleft lip/palate with characteristic facies, intestinal malrotation, and lethal congenital heart disease
|
[NCBI]
|
3.85601e-05
|
|
|
laryngeal abductor paralysis
|
[NCBI]
|
3.85601e-05
|
|
|
hyperthyroidism, familial gestational
|
[NCBI]
|
3.85601e-05
|
|
|
colchicine resistance
|
[NCBI]
|
3.85601e-05
|
|
|
carnevale syndrome
|
[NCBI]
|
3.85601e-05
|
|
|
3-@methylglutaconic aciduria, type iv
|
[NCBI]
|
3.85601e-05
|
|
|
craniostenosis, sagittal, with congenital heart disease, mental deficiency, and mandibular ankylosis
|
[NCBI]
|
3.85601e-05
|
|
|
electroencephalographic peculiarity: 14 and 6 per sec. positive spike phenomenon
|
[NCBI]
|
3.85601e-05
|
|
|
lithium transport
|
[NCBI]
|
3.85601e-05
|
|
|
holzgreve syndrome
|
[NCBI]
|
3.85601e-05
|
|
|
coarctation of aorta
|
[NCBI]
|
3.85601e-05
|
|
|
dk phocomelia syndrome
|
[NCBI]
|
3.85601e-05
|
|
|
sjogren-larsson-like ichthyosis without cns or eye involvement
|
[NCBI]
|
3.85601e-05
|
|
|
ankyloblepharon filiforme adnatum and cleft palate
|
[NCBI]
|
3.85601e-05
|
|
|
holoprosencephaly with fetal akinesia/hypokinesia sequence
|
[NCBI]
|
3.85601e-05
|
|
|
ehlers-danlos syndrome with platelet dysfunction from fibronectin abnormality
|
[NCBI]
|
3.85601e-05
|
|
|
aminopterin syndrome sine aminopterin
|
[NCBI]
|
3.85601e-05
|
|
|
lissencephaly type iii and bone dysplasia
|
[NCBI]
|
3.85601e-05
|
|
|
intrauterine growth retardation with increased mitomycin c sensitivity
|
[NCBI]
|
3.85601e-05
|
|
|
magnesium, elevated red cell
|
[NCBI]
|
3.85601e-05
|
|
|
larsen-like syndrome, lethal type
|
[NCBI]
|
3.85601e-05
|
|
|
epileptic encephalopathy, lennox-gastaut type
|
[NCBI]
|
3.85601e-05
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
3.80825e-05
|
|
|
histidinemia
|
[NCBI]
|
3.80825e-05
|
|
|
CGF1
|
[NCBI]
|
3.79675e-05
|
|
|
wernicke-korsakoff syndrome
|
[NCBI]
|
3.79675e-05
|
|
|
HBZ
|
[NCBI]
|
3.76903e-05
|
|
|
TS
|
[NCBI]
|
3.76871e-05
|
|
|
NF1
|
[NCBI]
|
3.76596e-05
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
3.70652e-05
|
|
|
aryl hydrocarbon hydroxylase inducibility
|
[NCBI]
|
3.70652e-05
|
|
|
PBT
|
[NCBI]
|
3.70652e-05
|
|
|
FCMD
|
[NCBI]
|
3.70283e-05
|
|
|
ACHE
|
[NCBI]
|
3.65517e-05
|
|
|
EV
|
[NCBI]
|
3.65039e-05
|
|
|
MS
|
[NCBI]
|
3.65039e-05
|
|
|
HADHA
|
[NCBI]
|
3.61379e-05
|
|
|
SMS
|
[NCBI]
|
3.59105e-05
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
3.5845e-05
|
|
|
MDC1A
|
[NCBI]
|
3.5845e-05
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
3.5845e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
3.5845e-05
|
|
|
ALPPL2
|
[NCBI]
|
3.58203e-05
|
|
|
ACPP
|
[NCBI]
|
3.52091e-05
|
|
|
XDH
|
[NCBI]
|
3.51269e-05
|
|
|
GIST
|
[NCBI]
|
3.49296e-05
|
|
|
EDN1
|
[NCBI]
|
3.46381e-05
|
|
|
SFRP4
|
[NCBI]
|
3.40671e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
3.39416e-05
|
|
|
WAS
|
[NCBI]
|
3.39251e-05
|
|
|
neuraminidase deficiency
|
[NCBI]
|
3.38922e-05
|
|
|
CLN1
|
[NCBI]
|
3.37514e-05
|
|
|
CHNG2
|
[NCBI]
|
3.37514e-05
|
|
|
MADD
|
[NCBI]
|
3.37514e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
3.37514e-05
|
|
|
OSM
|
[NCBI]
|
3.33019e-05
|
|
|
CHS
|
[NCBI]
|
3.30058e-05
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
3.29537e-05
|
|
|
COL6A1
|
[NCBI]
|
3.24689e-05
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
3.24061e-05
|
|
|
GFAP
|
[NCBI]
|
3.23217e-05
|
|
|
ABCB4
|
[NCBI]
|
3.21858e-05
|
|
|
SCDO1
|
[NCBI]
|
3.17887e-05
|
|
|
FRAP1
|
[NCBI]
|
3.16672e-05
|
|
|
IL2
|
[NCBI]
|
3.12464e-05
|
|
|
PGR
|
[NCBI]
|
3.10331e-05
|
|
|
OFC1
|
[NCBI]
|
3.09295e-05
|
|
|
SLS
|
[NCBI]
|
3.08629e-05
|
|
|
gaucher disease, type ii
|
[NCBI]
|
3.05453e-05
|
|
|
IHPS1
|
[NCBI]
|
3.05453e-05
|
|
|
DA2B
|
[NCBI]
|
3.05453e-05
|
|
|
FOLR1
|
[NCBI]
|
3.04752e-05
|
|
|
CGA
|
[NCBI]
|
3.04752e-05
|
|
|
MBP
|
[NCBI]
|
3.03225e-05
|
|
|
TLR2
|
[NCBI]
|
2.99852e-05
|
|
|
CNTF
|
[NCBI]
|
2.96866e-05
|
|
|
FCGRT
|
[NCBI]
|
2.94975e-05
|
|
|
ABCC1
|
[NCBI]
|
2.91535e-05
|
|
|
CP
|
[NCBI]
|
2.9132e-05
|
|
|
POMC
|
[NCBI]
|
2.89994e-05
|
|
|
IGFBP3
|
[NCBI]
|
2.89092e-05
|
|
|
cataract, microcephaly, failure to thrive, kyphoscoliosis syndrome
|
[NCBI]
|
2.88513e-05
|
|
|
PFIC3
|
[NCBI]
|
2.88513e-05
|
|
|
dyskeratosis congenita, autosomal recessive
|
[NCBI]
|
2.88513e-05
|
|
|
yemenite deaf-blind hypopigmentation syndrome
|
[NCBI]
|
2.88513e-05
|
|
|
phosphoglycerate dehydrogenase deficiency
|
[NCBI]
|
2.88513e-05
|
|
|
genitopalatocardiac syndrome
|
[NCBI]
|
2.88513e-05
|
|
|
xeroderma pigmentosum ix
|
[NCBI]
|
2.88513e-05
|
|
|
SERKAL
|
[NCBI]
|
2.88513e-05
|
|
|
combined saposin deficiency
|
[NCBI]
|
2.88513e-05
|
|
|
pterygium syndrome, multiple, x-linked
|
[NCBI]
|
2.88513e-05
|
|
|
GEMSS
|
[NCBI]
|
2.88513e-05
|
|
|
hypospadias, x-linked
|
[NCBI]
|
2.88513e-05
|
|
|
mydriatic response to pharmacologic agents
|
[NCBI]
|
2.88513e-05
|
|
|
DDSH
|
[NCBI]
|
2.88513e-05
|
|
|
barraquer-simons syndrome
|
[NCBI]
|
2.88513e-05
|
|
|
pierre robin syndrome
|
[NCBI]
|
2.88513e-05
|
|
|
MRX46
|
[NCBI]
|
2.88513e-05
|
|
|
S CHOICE OF
|
[NCBI]
|
2.88513e-05
|
|
|
dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema
|
[NCBI]
|
2.88513e-05
|
|
|
ovarian teratoma
|
[NCBI]
|
2.88513e-05
|
|
|
androstenone, ability to smell
|
[NCBI]
|
2.88513e-05
|
|
|
diabetes mellitus, permanent neonatal, with cerebellar agenesis
|
[NCBI]
|
2.88513e-05
|
|
|
sodium-potassium-atpase activity of red cell
|
[NCBI]
|
2.88513e-05
|
|
|
breasts and nipples, absence of
|
[NCBI]
|
2.88513e-05
|
|
|
brachydactyly, preaxial, with hallux varus and thumb abduction
|
[NCBI]
|
2.88513e-05
|
|
|
tetra-amelia, x-linked
|
[NCBI]
|
2.88513e-05
|
|
|
hydrocephalus due to congenital stenosis of aqueduct of sylvius
|
[NCBI]
|
2.88513e-05
|
|
|
leucine-rich repeat-containing g protein-coupled receptor 7
|
[NCBI]
|
2.88034e-05
|
|
|
BVES
|
[NCBI]
|
2.88034e-05
|
|
|
FSTL3
|
[NCBI]
|
2.85873e-05
|
|
|
RSTS
|
[NCBI]
|
2.83072e-05
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
2.81668e-05
|
|
|
erythrocytosis, familial, 1
|
[NCBI]
|
2.78242e-05
|
|
|
mulibrey nanism
|
[NCBI]
|
2.78242e-05
|
|
|
LDS
|
[NCBI]
|
2.78242e-05
|
|
|
pituitary dwarfism due to isolated growth hormone deficiency, autosomal dominant
|
[NCBI]
|
2.78242e-05
|
|
|
AEZ
|
[NCBI]
|
2.78242e-05
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
2.78242e-05
|
|
|
varadi-papp syndrome
|
[NCBI]
|
2.78058e-05
|
|
|
stiff skin syndrome
|
[NCBI]
|
2.78058e-05
|
|
|
HOS
|
[NCBI]
|
2.76136e-05
|
|
|
CYP19A1
|
[NCBI]
|
2.75896e-05
|
|
|
LAMA2
|
[NCBI]
|
2.74675e-05
|
|
|
HAE
|
[NCBI]
|
2.70504e-05
|
|
|
COMP
|
[NCBI]
|
2.6856e-05
|
|
|
PC
|
[NCBI]
|
2.66594e-05
|
|
|
PRLH
|
[NCBI]
|
2.64734e-05
|
|
|
NS1
|
[NCBI]
|
2.61958e-05
|
|
|
hypertelorism with esophageal abnormality and hypospadias
|
[NCBI]
|
2.61754e-05
|
|
|
GNB3
|
[NCBI]
|
2.61338e-05
|
|
|
PPARA
|
[NCBI]
|
2.60391e-05
|
|
|
DCK
|
[NCBI]
|
2.57604e-05
|
|
|
AR
|
[NCBI]
|
2.57434e-05
|
|
|
factor v deficiency
|
[NCBI]
|
2.54449e-05
|
|
|
FRA16A
|
[NCBI]
|
2.53842e-05
|
|
|
asplenia with cardiovascular anomalies
|
[NCBI]
|
2.53842e-05
|
|
|
MODY
|
[NCBI]
|
2.51603e-05
|
|
|
TLR4
|
[NCBI]
|
2.51564e-05
|
|
|
STAT3
|
[NCBI]
|
2.51087e-05
|
|
|
PSG3
|
[NCBI]
|
2.50635e-05
|
|
|
GH2
|
[NCBI]
|
2.50635e-05
|
|
|
PHS
|
[NCBI]
|
2.50375e-05
|
|
|
POF1
|
[NCBI]
|
2.50375e-05
|
|
|
MTHFR
|
[NCBI]
|
2.49856e-05
|
|
|
PMP22
|
[NCBI]
|
2.48513e-05
|
|
|
CAT
|
[NCBI]
|
2.48297e-05
|
|
|
IGF2R
|
[NCBI]
|
2.47392e-05
|
|
|
GRP
|
[NCBI]
|
2.46699e-05
|
|
|
STAT5A
|
[NCBI]
|
2.45801e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
2.45358e-05
|
|
|
PTGS2
|
[NCBI]
|
2.45259e-05
|
|
|
SST
|
[NCBI]
|
2.44887e-05
|
|
|
TEAD3
|
[NCBI]
|
2.38796e-05
|
|
|
CGB8
|
[NCBI]
|
2.38796e-05
|
|
|
IPP
|
[NCBI]
|
2.38796e-05
|
|
|
SPINT2
|
[NCBI]
|
2.38796e-05
|
|
|
CGB5
|
[NCBI]
|
2.38796e-05
|
|
|
CGB7
|
[NCBI]
|
2.38796e-05
|
|
|
apert syndrome
|
[NCBI]
|
2.3583e-05
|
|
|
OMP
|
[NCBI]
|
2.34061e-05
|
|
|
APRT
|
[NCBI]
|
2.32799e-05
|
|
|
HOXA10
|
[NCBI]
|
2.32703e-05
|
|
|
TNFSF10
|
[NCBI]
|
2.32198e-05
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
2.31835e-05
|
|
|
nondisjunction
|
[NCBI]
|
2.31835e-05
|
|
|
MCPH1
|
[NCBI]
|
2.31835e-05
|
|
|
HPE3
|
[NCBI]
|
2.31835e-05
|
|
|
omenn syndrome
|
[NCBI]
|
2.31835e-05
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
2.31835e-05
|
|
|
VIM
|
[NCBI]
|
2.29624e-05
|
|
|
HAE III
|
[NCBI]
|
2.28179e-05
|
|
|
donnai-barrow syndrome
|
[NCBI]
|
2.28179e-05
|
|
|
carboxypeptidase n deficiency
|
[NCBI]
|
2.28179e-05
|
|
|
CDG1D
|
[NCBI]
|
2.28179e-05
|
|
|
FANCI
|
[NCBI]
|
2.28179e-05
|
|
|
pancreatic agenesis, congenital
|
[NCBI]
|
2.28179e-05
|
|
|
hand clasping pattern
|
[NCBI]
|
2.28179e-05
|
|
|
fanconi anemia, complementation group j
|
[NCBI]
|
2.28179e-05
|
|
|
bietti crystalline corneoretinal dystrophy
|
[NCBI]
|
2.28179e-05
|
|
|
acth deficiency
|
[NCBI]
|
2.28179e-05
|
|
|
CDG1K
|
[NCBI]
|
2.28179e-05
|
|
|
2-@methylbutyryl-coa dehydrogenase deficiency
|
[NCBI]
|
2.28179e-05
|
|
|
hyperlysinemia
|
[NCBI]
|
2.28179e-05
|
|
|
martsolf syndrome
|
[NCBI]
|
2.28179e-05
|
|
|
goodpasture syndrome
|
[NCBI]
|
2.28179e-05
|
|
|
respiratory underresponsiveness to hypoxia and hypercapnia
|
[NCBI]
|
2.28179e-05
|
|
|
tongue curling, folding, or rolling
|
[NCBI]
|
2.28179e-05
|
|
|
corpus callosum, partial agenesis of, x-linked
|
[NCBI]
|
2.28179e-05
|
|
|
pyruvate dehydrogenase phosphatase deficiency
|
[NCBI]
|
2.28179e-05
|
|
|
RD
|
[NCBI]
|
2.28179e-05
|
|
|
ectopia lentis
|
[NCBI]
|
2.28179e-05
|
|
|
endocardial fibroelastosis
|
[NCBI]
|
2.28179e-05
|
|
|
femur-fibula-ulna syndrome
|
[NCBI]
|
2.28179e-05
|
|
|
mevalonic aciduria
|
[NCBI]
|
2.28179e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
2.28002e-05
|
|
|
homocysteinemia
|
[NCBI]
|
2.22082e-05
|
|
|
graves disease
|
[NCBI]
|
2.22082e-05
|
|
|
SCZD
|
[NCBI]
|
2.21407e-05
|
|
|
ND
|
[NCBI]
|
2.19671e-05
|
|
|
AOS
|
[NCBI]
|
2.19085e-05
|
|
|
PXE
|
[NCBI]
|
2.17386e-05
|
|
|
HLA-G
|
[NCBI]
|
2.1644e-05
|
|
|
LDLR
|
[NCBI]
|
2.13851e-05
|
|
|
BDNF
|
[NCBI]
|
2.09964e-05
|
|
|
DFSP
|
[NCBI]
|
2.09725e-05
|
|
|
CALCRL
|
[NCBI]
|
2.07905e-05
|
|
|
CYP27B1
|
[NCBI]
|
2.069e-05
|
|
|
NR2C2
|
[NCBI]
|
2.05655e-05
|
|
|
DIO3
|
[NCBI]
|
2.05655e-05
|
|
|
ESX1L
|
[NCBI]
|
2.05655e-05
|
|
|
CGB2
|
[NCBI]
|
2.05655e-05
|
|
|
CGB1
|
[NCBI]
|
2.05655e-05
|
|
|
MYH3
|
[NCBI]
|
2.05655e-05
|
|
|
HPA-2
|
[NCBI]
|
2.05655e-05
|
|
|
LAMA4
|
[NCBI]
|
2.05655e-05
|
|
|
CACYBP
|
[NCBI]
|
2.05655e-05
|
|
|
KRT8
|
[NCBI]
|
2.0258e-05
|
|
|
NCOA6
|
[NCBI]
|
2.0258e-05
|
|
|
INDO
|
[NCBI]
|
2.0258e-05
|
|
|
apc gene
|
[NCBI]
|
2.00109e-05
|
|
|
DSCR4
|
[NCBI]
|
1.99763e-05
|
|
|
CHCHD1
|
[NCBI]
|
1.99763e-05
|
|
|
chondroitin sulfate synthase 3
|
[NCBI]
|
1.99763e-05
|
|
|
UBE2D3
|
[NCBI]
|
1.99763e-05
|
|
|
MYL9
|
[NCBI]
|
1.99763e-05
|
|
|
microfibril-associated glycoprotein 2
|
[NCBI]
|
1.99763e-05
|
|
|
BCL8
|
[NCBI]
|
1.99763e-05
|
|
|
zinc finger protein zk1
|
[NCBI]
|
1.99763e-05
|
|
|
SOX12
|
[NCBI]
|
1.99763e-05
|
|
|
RAB11B
|
[NCBI]
|
1.99763e-05
|
|
|
C22ORF1
|
[NCBI]
|
1.99763e-05
|
|
|
fc receptor-like protein 2
|
[NCBI]
|
1.99763e-05
|
|
|
TFAP2D
|
[NCBI]
|
1.99763e-05
|
|
|
popeye protein 3
|
[NCBI]
|
1.99763e-05
|
|
|
HTRA3
|
[NCBI]
|
1.99763e-05
|
|
|
RAB35
|
[NCBI]
|
1.99763e-05
|
|
|
ANP32E
|
[NCBI]
|
1.99763e-05
|
|
|
ARMCX3
|
[NCBI]
|
1.99763e-05
|
|
|
SPTLC3
|
[NCBI]
|
1.99763e-05
|
|
|
ZAKI4
|
[NCBI]
|
1.99763e-05
|
|
|
EIF3D
|
[NCBI]
|
1.99763e-05
|
|
|
RAB7L1
|
[NCBI]
|
1.99763e-05
|
|
|
plasticity-related gene 2
|
[NCBI]
|
1.99763e-05
|
|
|
trophoblast-lymphocyte crossreactive antigen
|
[NCBI]
|
1.99763e-05
|
|
|
GAK
|
[NCBI]
|
1.99763e-05
|
|
|
laeverin
|
[NCBI]
|
1.99763e-05
|
|
|
ARMCX3
|
[NCBI]
|
1.99763e-05
|
|
|
FBS1
|
[NCBI]
|
1.99763e-05
|
|
|
CCNB2
|
[NCBI]
|
1.99763e-05
|
|
|
CLIC5
|
[NCBI]
|
1.99763e-05
|
|
|
TAC3
|
[NCBI]
|
1.99763e-05
|
|
|
EIF3F
|
[NCBI]
|
1.99763e-05
|
|
|
popeye protein 2
|
[NCBI]
|
1.99763e-05
|
|
|
pregnancy-induced growth inhibitor okl38
|
[NCBI]
|
1.99763e-05
|
|
|
OLFML3
|
[NCBI]
|
1.99763e-05
|
|
|
C21ORF7
|
[NCBI]
|
1.99763e-05
|
|
|
dipla1, antisense
|
[NCBI]
|
1.99763e-05
|
|
|
GGTLA1
|
[NCBI]
|
1.99763e-05
|
|
|
TNK1
|
[NCBI]
|
1.99763e-05
|
|
|
COPG2IT1
|
[NCBI]
|
1.99763e-05
|
|
|
RHD
|
[NCBI]
|
1.97905e-05
|
|
|
WDM
|
[NCBI]
|
1.97832e-05
|
|
|
OTSC1
|
[NCBI]
|
1.97832e-05
|
|
|
JMML
|
[NCBI]
|
1.9589e-05
|
|
|
down syndrome
|
[NCBI]
|
1.9535e-05
|
|
|
GRA
|
[NCBI]
|
1.9535e-05
|
|
|
blood group, p system
|
[NCBI]
|
1.93733e-05
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
1.93733e-05
|
|
|
molybdenum cofactor deficiency
|
[NCBI]
|
1.93733e-05
|
|
|
GAL
|
[NCBI]
|
1.91991e-05
|
|
|
MEST
|
[NCBI]
|
1.89727e-05
|
|
|
ITGA2
|
[NCBI]
|
1.89727e-05
|
|
|
CDK2
|
[NCBI]
|
1.88991e-05
|
|
|
SLPI
|
[NCBI]
|
1.88072e-05
|
|
|
ILK
|
[NCBI]
|
1.87794e-05
|
|
|
peroxisomal acyl-coa oxidase deficiency
|
[NCBI]
|
1.85301e-05
|
|
|
GCS1
|
[NCBI]
|
1.85301e-05
|
|
|
OPTB5
|
[NCBI]
|
1.85301e-05
|
|
|
young syndrome
|
[NCBI]
|
1.85301e-05
|
|
|
microcephaly with spastic quadriplegia
|
[NCBI]
|
1.85301e-05
|
|
|
recombinant chromosome 8 syndrome
|
[NCBI]
|
1.85301e-05
|
|
|
paroxysmal extreme pain disorder
|
[NCBI]
|
1.85301e-05
|
|
|
cerebrocostomandibular syndrome
|
[NCBI]
|
1.85301e-05
|
|
|
IN
|
[NCBI]
|
1.85301e-05
|
|
|
WARBM
|
[NCBI]
|
1.85301e-05
|
|
|
intracranial hypertension, idiopathic
|
[NCBI]
|
1.85301e-05
|
|
|
RCDP3
|
[NCBI]
|
1.85301e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type ii
|
[NCBI]
|
1.85301e-05
|
|
|
aromatic l-amino acid decarboxylase deficiency
|
[NCBI]
|
1.85301e-05
|
|
|
niemann-pick disease, type c2
|
[NCBI]
|
1.85301e-05
|
|
|
oculocerebrocutaneous syndrome
|
[NCBI]
|
1.85301e-05
|
|
|
macrocephaly, benign familial
|
[NCBI]
|
1.85301e-05
|
|
|
porencephaly, familial
|
[NCBI]
|
1.85301e-05
|
|
|
lichen planus, familial
|
[NCBI]
|
1.85301e-05
|
|
|
ebstein anomaly
|
[NCBI]
|
1.85301e-05
|
|
|
white sponge nevus of cannon
|
[NCBI]
|
1.85301e-05
|
|
|
eunuchoidism, familial hypogonadotropic
|
[NCBI]
|
1.85301e-05
|
|
|
shprintzen-goldberg craniosynostosis syndrome
|
[NCBI]
|
1.85301e-05
|
|
|
epidermolysis bullosa herpetiformis, dowling-meara type
|
[NCBI]
|
1.85301e-05
|
|
|
respiratory distress syndrome in premature infants
|
[NCBI]
|
1.85301e-05
|
|
|
3-@methylglutaconic aciduria, type iii
|
[NCBI]
|
1.85301e-05
|
|
|
CDHS
|
[NCBI]
|
1.85301e-05
|
|
|
osteogenesis imperfecta, type viii
|
[NCBI]
|
1.85301e-05
|
|
|
costello syndrome
|
[NCBI]
|
1.851e-05
|
|
|
ARF4
|
[NCBI]
|
1.80751e-05
|
|
|
CSHL1
|
[NCBI]
|
1.80751e-05
|
|
|
GGTA1
|
[NCBI]
|
1.80751e-05
|
|
|
KLF7
|
[NCBI]
|
1.80751e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
1.80244e-05
|
|
|
PSAP
|
[NCBI]
|
1.79134e-05
|
|
|
CASR
|
[NCBI]
|
1.79032e-05
|
|
|
RNR1
|
[NCBI]
|
1.78037e-05
|
|
|
glycogen storage disease iv
|
[NCBI]
|
1.77154e-05
|
|
|
OFD1
|
[NCBI]
|
1.77154e-05
|
|
|
factor xii deficiency
|
[NCBI]
|
1.77154e-05
|
|
|
pituitary dwarfism i
|
[NCBI]
|
1.77154e-05
|
|
|
GAPDH
|
[NCBI]
|
1.74379e-05
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
1.74169e-05
|
|
|
FGF4
|
[NCBI]
|
1.73732e-05
|
|
|
HBB
|
[NCBI]
|
1.73041e-05
|
|
|
ACP5
|
[NCBI]
|
1.73015e-05
|
|
|
ECE1
|
[NCBI]
|
1.67341e-05
|
|
|
PTPN1
|
[NCBI]
|
1.66486e-05
|
|
|
LIF
|
[NCBI]
|
1.64751e-05
|
|
|
CDPX2
|
[NCBI]
|
1.63557e-05
|
|
|
TBS
|
[NCBI]
|
1.63557e-05
|
|
|
FGFR3
|
[NCBI]
|
1.62939e-05
|
|
|
TTDP
|
[NCBI]
|
1.61968e-05
|
|
|
LAMA1
|
[NCBI]
|
1.60918e-05
|
|
|
TRPV6
|
[NCBI]
|
1.60918e-05
|
|
|
LAG5
|
[NCBI]
|
1.60918e-05
|
|
|
MMP8
|
[NCBI]
|
1.60918e-05
|
|
|
FANCB
|
[NCBI]
|
1.60918e-05
|
|
|
HRK
|
[NCBI]
|
1.60918e-05
|
|
|
ED1
|
[NCBI]
|
1.60818e-05
|
|
|
CEACAM5
|
[NCBI]
|
1.60407e-05
|
|
|
HMBS
|
[NCBI]
|
1.59998e-05
|
|
|
H19
|
[NCBI]
|
1.59411e-05
|
|
|
AIS
|
[NCBI]
|
1.59357e-05
|
|
|
JARID2
|
[NCBI]
|
1.57506e-05
|
|
|
CDH2
|
[NCBI]
|
1.57506e-05
|
|
|
SLC19A1
|
[NCBI]
|
1.57506e-05
|
|
|
STAT1
|
[NCBI]
|
1.5657e-05
|
|
|
WT1
|
[NCBI]
|
1.56056e-05
|
|
|
COL1A2
|
[NCBI]
|
1.54915e-05
|
|
|
MDLS
|
[NCBI]
|
1.53608e-05
|
|
|
PMCH
|
[NCBI]
|
1.53587e-05
|
|
|
CHM
|
[NCBI]
|
1.52989e-05
|
|
|
hurler syndrome
|
[NCBI]
|
1.52989e-05
|
|
|
mental retardation, fra12a type
|
[NCBI]
|
1.52704e-05
|
|
|
STHAG1
|
[NCBI]
|
1.52704e-05
|
|
|
methylmalonic aciduria, cbla type
|
[NCBI]
|
1.52704e-05
|
|
|
HAM
|
[NCBI]
|
1.52704e-05
|
|
|
LIS2
|
[NCBI]
|
1.52704e-05
|
|
|
ectopia lentis, isolated
|
[NCBI]
|
1.52704e-05
|
|
|
pyruvate dehydrogenase e3-binding protein deficiency
|
[NCBI]
|
1.52704e-05
|
|
|
OCA1B
|
[NCBI]
|
1.52704e-05
|
|
|
osseous heteroplasia, progressive
|
[NCBI]
|
1.52704e-05
|
|
|
creatine phosphokinase, elevated serum
|
[NCBI]
|
1.52704e-05
|
|
|
hemoglobin--variants for which the chain carrying the mutation is unknown or uncertain
|
[NCBI]
|
1.52704e-05
|
|
|
GRTH
|
[NCBI]
|
1.52704e-05
|
|
|
thrombophilia
|
[NCBI]
|
1.52704e-05
|
|
|
thyroxine-binding globulin of serum
|
[NCBI]
|
1.52704e-05
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
1.52704e-05
|
|
|
whistling face syndrome, recessive form
|
[NCBI]
|
1.52704e-05
|
|
|
acrofacial dysostosis syndrome of rodriguez
|
[NCBI]
|
1.52704e-05
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
1.52445e-05
|
|
|
CEL
|
[NCBI]
|
1.52034e-05
|
|
|
IGFALS
|
[NCBI]
|
1.5063e-05
|
|
|
CBX5
|
[NCBI]
|
1.49746e-05
|
|
|
MBL2
|
[NCBI]
|
1.48704e-05
|
|
|
DA2A
|
[NCBI]
|
1.48025e-05
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
1.48025e-05
|
|
|
HBD
|
[NCBI]
|
1.47927e-05
|
|
|
XIST
|
[NCBI]
|
1.46894e-05
|
|
|
ALDH1A2
|
[NCBI]
|
1.46776e-05
|
|
|
TBP
|
[NCBI]
|
1.46351e-05
|
|
|
alopecia, androgenetic
|
[NCBI]
|
1.44951e-05
|
|
|
GPX3
|
[NCBI]
|
1.44535e-05
|
|
|
PDE5A
|
[NCBI]
|
1.44535e-05
|
|
|
INHBB
|
[NCBI]
|
1.44535e-05
|
|
|
SLC31A1
|
[NCBI]
|
1.44535e-05
|
|
|
CHRNG
|
[NCBI]
|
1.44535e-05
|
|
|
CDG1A
|
[NCBI]
|
1.44165e-05
|
|
|
ENPEP
|
[NCBI]
|
1.43927e-05
|
|
|
ADM
|
[NCBI]
|
1.43625e-05
|
|
|
RBP1
|
[NCBI]
|
1.40606e-05
|
|
|
PTS
|
[NCBI]
|
1.4e-05
|
|
|
LTF
|
[NCBI]
|
1.4e-05
|
|
|
SMA1
|
[NCBI]
|
1.3989e-05
|
|
|
HFE
|
[NCBI]
|
1.37231e-05
|
|
|
cutis laxa, x-linked
|
[NCBI]
|
1.35197e-05
|
|
|
EBR1
|
[NCBI]
|
1.35197e-05
|
|
|
UCMD
|
[NCBI]
|
1.35197e-05
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
1.35197e-05
|
|
|
DCN
|
[NCBI]
|
1.35097e-05
|
|
|
marden-walker syndrome
|
[NCBI]
|
1.35093e-05
|
|
|
FGF9
|
[NCBI]
|
1.32166e-05
|
|
|
TKT
|
[NCBI]
|
1.32166e-05
|
|
|
ADCYAP1
|
[NCBI]
|
1.31414e-05
|
|
|
CDK4
|
[NCBI]
|
1.31324e-05
|
|
|
SOD1
|
[NCBI]
|
1.31252e-05
|
|
|
ABCB11
|
[NCBI]
|
1.30779e-05
|
|
|
PSG2
|
[NCBI]
|
1.30659e-05
|
|
|
CYP3A7
|
[NCBI]
|
1.30659e-05
|
|
|
PRG2
|
[NCBI]
|
1.30659e-05
|
|
|
PTF1A
|
[NCBI]
|
1.30659e-05
|
|
|
FDX1
|
[NCBI]
|
1.30659e-05
|
|
|
LAMC2
|
[NCBI]
|
1.30659e-05
|
|
|
HOXC8
|
[NCBI]
|
1.30659e-05
|
|
|
MTRR
|
[NCBI]
|
1.30659e-05
|
|
|
F2RL3
|
[NCBI]
|
1.30659e-05
|
|
|
NEUROG2
|
[NCBI]
|
1.30659e-05
|
|
|
NGFB
|
[NCBI]
|
1.29003e-05
|
|
|
ESR1
|
[NCBI]
|
1.27641e-05
|
|
|
hand-foot-uterus syndrome
|
[NCBI]
|
1.269e-05
|
|
|
hypospadias, autosomal
|
[NCBI]
|
1.269e-05
|
|
|
KNO
|
[NCBI]
|
1.269e-05
|
|
|
ulna and fibula, absence of, with severe limb deficiency
|
[NCBI]
|
1.269e-05
|
|
|
xeroderma pigmentosum, complementation group e
|
[NCBI]
|
1.269e-05
|
|
|
hyperthyroidism, nonautoimmune
|
[NCBI]
|
1.269e-05
|
|
|
pierson syndrome
|
[NCBI]
|
1.269e-05
|
|
|
congenital disorder of glycosylation, type i/iix
|
[NCBI]
|
1.269e-05
|
|
|
twinning, monozygotic
|
[NCBI]
|
1.269e-05
|
|
|
halothane hepatitis
|
[NCBI]
|
1.269e-05
|
|
|
succinyl-coa:3-oxoacid coa transferase deficiency
|
[NCBI]
|
1.269e-05
|
|
|
AN1
|
[NCBI]
|
1.269e-05
|
|
|
avascular necrosis of femoral head, primary
|
[NCBI]
|
1.269e-05
|
|
|
megalencephaly-cutis marmorata telangiectatica congenita
|
[NCBI]
|
1.269e-05
|
|
|
fragile site 2q11
|
[NCBI]
|
1.269e-05
|
|
|
ACE
|
[NCBI]
|
1.26563e-05
|
|
|
PDCD8
|
[NCBI]
|
1.26287e-05
|
|
|
NEU1
|
[NCBI]
|
1.24859e-05
|
|
|
faciogenital dysplasia
|
[NCBI]
|
1.23374e-05
|
|
|
APP
|
[NCBI]
|
1.21123e-05
|
|
|
DNMT1
|
[NCBI]
|
1.21123e-05
|
|
|
CMT1A
|
[NCBI]
|
1.20936e-05
|
|
|
SMAX1
|
[NCBI]
|
1.2033e-05
|
|
|
NOL4
|
[NCBI]
|
1.19395e-05
|
|
|
SIGLEC6
|
[NCBI]
|
1.19395e-05
|
|
|
NANS
|
[NCBI]
|
1.19395e-05
|
|
|
IQWD1
|
[NCBI]
|
1.19395e-05
|
|
|
ZPBP
|
[NCBI]
|
1.19395e-05
|
|
|
PPP1R7
|
[NCBI]
|
1.19395e-05
|
|
|
HS3ST5
|
[NCBI]
|
1.19395e-05
|
|
|
ZNF195
|
[NCBI]
|
1.19395e-05
|
|
|
DMWD
|
[NCBI]
|
1.19395e-05
|
|
|
ZP2
|
[NCBI]
|
1.19395e-05
|
|
|
skin-, embryo-, brain-, and oocyte-specific homeobox
|
[NCBI]
|
1.19395e-05
|
|
|
placental protein 11
|
[NCBI]
|
1.19395e-05
|
|
|
FBXO27
|
[NCBI]
|
1.19395e-05
|
|
|
SHOXY
|
[NCBI]
|
1.19395e-05
|
|
|
DNAJC9
|
[NCBI]
|
1.19395e-05
|
|
|
RLN3
|
[NCBI]
|
1.19395e-05
|
|
|
PPP2R3B
|
[NCBI]
|
1.19395e-05
|
|
|
xiap-associated factor 1
|
[NCBI]
|
1.19395e-05
|
|
|
GALNT2
|
[NCBI]
|
1.19395e-05
|
|
|
FGF22
|
[NCBI]
|
1.19395e-05
|
|
|
CPXM
|
[NCBI]
|
1.19395e-05
|
|
|
BARHL2
|
[NCBI]
|
1.19395e-05
|
|
|
DUSP4
|
[NCBI]
|
1.19395e-05
|
|
|
EMILIN3
|
[NCBI]
|
1.19395e-05
|
|
|
progesterone-induced blocking factor 1
|
[NCBI]
|
1.19395e-05
|
|
|
SLCO2B1
|
[NCBI]
|
1.19395e-05
|
|
|
ERVE1
|
[NCBI]
|
1.19395e-05
|
|
|
ste20-related adaptor protein
|
[NCBI]
|
1.19395e-05
|
|
|
CPA5
|
[NCBI]
|
1.19395e-05
|
|
|
TBX20
|
[NCBI]
|
1.19395e-05
|
|
|
MMP19
|
[NCBI]
|
1.19395e-05
|
|
|
OVGP1
|
[NCBI]
|
1.19395e-05
|
|
|
MRX49
|
[NCBI]
|
1.19395e-05
|
|
|
DTL
|
[NCBI]
|
1.19395e-05
|
|
|
SULT2B1
|
[NCBI]
|
1.19395e-05
|
|
|
BRS3
|
[NCBI]
|
1.19395e-05
|
|
|
KCNE4
|
[NCBI]
|
1.19395e-05
|
|
|
PMVK
|
[NCBI]
|
1.19395e-05
|
|
|
LAPTM5
|
[NCBI]
|
1.19395e-05
|
|
|
B3GAT3
|
[NCBI]
|
1.19395e-05
|
|
|
DONSON
|
[NCBI]
|
1.19395e-05
|
|
|
PI14
|
[NCBI]
|
1.19395e-05
|
|
|
HOXB13
|
[NCBI]
|
1.19395e-05
|
|
|
ARMCX2
|
[NCBI]
|
1.19395e-05
|
|
|
SLC29A1
|
[NCBI]
|
1.18686e-05
|
|
|
ARTN
|
[NCBI]
|
1.18686e-05
|
|
|
HBE1
|
[NCBI]
|
1.18686e-05
|
|
|
MGAT1
|
[NCBI]
|
1.18686e-05
|
|
|
A4GALT
|
[NCBI]
|
1.18686e-05
|
|
|
ATP8B1
|
[NCBI]
|
1.18686e-05
|
|
|
RAMP2
|
[NCBI]
|
1.18686e-05
|
|
|
GPR54
|
[NCBI]
|
1.18024e-05
|
|
|
FLT1
|
[NCBI]
|
1.18024e-05
|
|
|
FMR1
|
[NCBI]
|
1.16921e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.1536e-05
|
|
|
TPMT
|
[NCBI]
|
1.13095e-05
|
|
|
GJB1
|
[NCBI]
|
1.13095e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
1.12463e-05
|
|
|
ALD
|
[NCBI]
|
1.11893e-05
|
|
|
EBP
|
[NCBI]
|
1.11616e-05
|
|
|
LPO
|
[NCBI]
|
1.11469e-05
|
|
|
ATM
|
[NCBI]
|
1.11469e-05
|
|
|
MUC1
|
[NCBI]
|
1.11151e-05
|
|
|
PRKCM
|
[NCBI]
|
1.0823e-05
|
|
|
SLC2A3
|
[NCBI]
|
1.08211e-05
|
|
|
INHA
|
[NCBI]
|
1.08211e-05
|
|
|
RTN1
|
[NCBI]
|
1.08211e-05
|
|
|
COL5A2
|
[NCBI]
|
1.08211e-05
|
|
|
AGT
|
[NCBI]
|
1.07428e-05
|
|
|
MEN2A
|
[NCBI]
|
1.07078e-05
|
|
|
wilson disease
|
[NCBI]
|
1.06652e-05
|
|
|
PAM
|
[NCBI]
|
1.06617e-05
|
|
|
SHH
|
[NCBI]
|
1.06362e-05
|
|
|
VHL
|
[NCBI]
|
1.06177e-05
|
|
|
hyperprolinemia, type i
|
[NCBI]
|
1.05925e-05
|
|
|
takayasu arteritis
|
[NCBI]
|
1.05925e-05
|
|
|
mast cell disease
|
[NCBI]
|
1.05925e-05
|
|
|
de sanctis-cacchione syndrome
|
[NCBI]
|
1.05925e-05
|
|
|
deafness, aminoglycoside-induced
|
[NCBI]
|
1.05925e-05
|
|
|
EPD
|
[NCBI]
|
1.05925e-05
|
|
|
HYR
|
[NCBI]
|
1.05925e-05
|
|
|
carnitine palmitoyltransferase i deficiency
|
[NCBI]
|
1.05925e-05
|
|
|
globozoospermia
|
[NCBI]
|
1.05925e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
1.05925e-05
|
|
|
ehlers-danlos syndrome, type vii, autosomal recessive
|
[NCBI]
|
1.05925e-05
|
|
|
MRX9
|
[NCBI]
|
1.05925e-05
|
|
|
hyperbilirubinemia, transient familial neonatal
|
[NCBI]
|
1.05925e-05
|
|
|
ADA
|
[NCBI]
|
1.04792e-05
|
|
|
PROCR
|
[NCBI]
|
1.03918e-05
|
|
|
SLC6A4
|
[NCBI]
|
1.03765e-05
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
1.03633e-05
|
|
|
PEMT
|
[NCBI]
|
1.01343e-05
|
|
|
wolman disease
|
[NCBI]
|
1.01343e-05
|
|
|
CHAT
|
[NCBI]
|
1.00831e-05
|
|
|
LOX
|
[NCBI]
|
1.00191e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
1.00187e-05
|
|
|
HNF1B
|
[NCBI]
|
9.99325e-06
|
|
|
PMM2
|
[NCBI]
|
9.99325e-06
|
|
|
IGFBP1
|
[NCBI]
|
9.89432e-06
|
|
|
SEPT5
|
[NCBI]
|
9.89432e-06
|
|
|
ECGF1
|
[NCBI]
|
9.89432e-06
|
|
|
PSPN
|
[NCBI]
|
9.89432e-06
|
|
|
TNFSF11
|
[NCBI]
|
9.86141e-06
|
|
|
ALK
|
[NCBI]
|
9.77939e-06
|
|
|
PPT1
|
[NCBI]
|
9.7264e-06
|
|
|
AGTR1
|
[NCBI]
|
9.7264e-06
|
|
|
IFNA1
|
[NCBI]
|
9.70269e-06
|
|
|
PCI
|
[NCBI]
|
9.70269e-06
|
|
|
DMD
|
[NCBI]
|
9.65509e-06
|
|
|
giant platelet syndrome
|
[NCBI]
|
9.5254e-06
|
|
|
HK1
|
[NCBI]
|
9.45928e-06
|
|
|
PLK1
|
[NCBI]
|
9.43972e-06
|
|
|
UMOD
|
[NCBI]
|
9.33415e-06
|
|
|
charge syndrome
|
[NCBI]
|
9.30617e-06
|
|
|
SEDC
|
[NCBI]
|
9.30617e-06
|
|
|
OCRL
|
[NCBI]
|
9.30617e-06
|
|
|
AHC
|
[NCBI]
|
9.30617e-06
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
9.30617e-06
|
|
|
PIGR
|
[NCBI]
|
9.07251e-06
|
|
|
GDF11
|
[NCBI]
|
9.06715e-06
|
|
|
SEMA3F
|
[NCBI]
|
9.06715e-06
|
|
|
MEG3
|
[NCBI]
|
9.06715e-06
|
|
|
PSAT1
|
[NCBI]
|
9.03728e-06
|
|
|
HKR3
|
[NCBI]
|
9.03728e-06
|
|
|
MMP16
|
[NCBI]
|
9.03728e-06
|
|
|
GPR49
|
[NCBI]
|
9.03728e-06
|
|
|
UBA52
|
[NCBI]
|
9.03728e-06
|
|
|
FZD1
|
[NCBI]
|
9.03728e-06
|
|
|
ST3GAL3
|
[NCBI]
|
9.03728e-06
|
|
|
COL16A1
|
[NCBI]
|
9.03728e-06
|
|
|
REQ
|
[NCBI]
|
9.03728e-06
|
|
|
plasticity-related gene 1
|
[NCBI]
|
9.03728e-06
|
|
|
TIMM13
|
[NCBI]
|
9.03728e-06
|
|
|
KCND2
|
[NCBI]
|
9.03728e-06
|
|
|
NAB2
|
[NCBI]
|
9.03728e-06
|
|
|
CSDA
|
[NCBI]
|
9.03728e-06
|
|
|
nucleoporin, 210-kd
|
[NCBI]
|
9.03728e-06
|
|
|
DPPA5
|
[NCBI]
|
9.03728e-06
|
|
|
FBXO17
|
[NCBI]
|
9.03728e-06
|
|
|
KIR3DL3
|
[NCBI]
|
9.03728e-06
|
|
|
RGS10
|
[NCBI]
|
9.03728e-06
|
|
|
GALNT1
|
[NCBI]
|
9.03728e-06
|
|
|
SPTLC2
|
[NCBI]
|
9.03728e-06
|
|
|
MAFF
|
[NCBI]
|
9.03728e-06
|
|
|
RPS6KA2
|
[NCBI]
|
9.03728e-06
|
|
|
PI8
|
[NCBI]
|
9.03728e-06
|
|
|
TPBG
|
[NCBI]
|
9.03728e-06
|
|
|
MFAP2
|
[NCBI]
|
9.03728e-06
|
|
|
COPG2
|
[NCBI]
|
9.03728e-06
|
|
|
AGTPBP1
|
[NCBI]
|
9.03728e-06
|
|
|
BYSL
|
[NCBI]
|
9.03728e-06
|
|
|
TMOD2
|
[NCBI]
|
9.03728e-06
|
|
|
PIP5K2A
|
[NCBI]
|
9.03728e-06
|
|
|
GPR65
|
[NCBI]
|
9.03728e-06
|
|
|
EIF3H
|
[NCBI]
|
9.03728e-06
|
|
|
UCK2
|
[NCBI]
|
9.03728e-06
|
|
|
RNH
|
[NCBI]
|
9.03728e-06
|
|
|
DMBX1
|
[NCBI]
|
9.03728e-06
|
|
|
TRG2
|
[NCBI]
|
9.03728e-06
|
|
|
ANGPT4
|
[NCBI]
|
9.03728e-06
|
|
|
FZD7
|
[NCBI]
|
9.03728e-06
|
|
|
SLC35D1
|
[NCBI]
|
9.03728e-06
|
|
|
GLRX
|
[NCBI]
|
9.03728e-06
|
|
|
PCSK4
|
[NCBI]
|
9.03728e-06
|
|
|
OR2H3
|
[NCBI]
|
9.03728e-06
|
|
|
FBXO44
|
[NCBI]
|
9.03728e-06
|
|
|
BCL5
|
[NCBI]
|
9.03728e-06
|
|
|
AKAP8L
|
[NCBI]
|
9.03728e-06
|
|
|
PCDH17
|
[NCBI]
|
9.03728e-06
|
|
|
ZNF365
|
[NCBI]
|
9.03728e-06
|
|
|
LOXL3
|
[NCBI]
|
9.03728e-06
|
|
|
SMARCA1
|
[NCBI]
|
9.03728e-06
|
|
|
DIRAS3
|
[NCBI]
|
9.03728e-06
|
|
|
ADM2
|
[NCBI]
|
9.03728e-06
|
|
|
CYP26B1
|
[NCBI]
|
9.03728e-06
|
|
|
LYPD3
|
[NCBI]
|
9.03728e-06
|
|
|
UBE2D2
|
[NCBI]
|
9.03728e-06
|
|
|
PRRX2
|
[NCBI]
|
9.03728e-06
|
|
|
TMEM67
|
[NCBI]
|
9.03728e-06
|
|
|
FOLR2
|
[NCBI]
|
9.03728e-06
|
|
|
fifth ewing sarcoma variant
|
[NCBI]
|
9.03728e-06
|
|
|
GSTA1
|
[NCBI]
|
9.03728e-06
|
|
|
ATP6V0A2
|
[NCBI]
|
9.03728e-06
|
|
|
EMX1
|
[NCBI]
|
9.03728e-06
|
|
|
C6ORF32
|
[NCBI]
|
9.03728e-06
|
|
|
NFIC
|
[NCBI]
|
9.03728e-06
|
|
|
CYLN2
|
[NCBI]
|
9.03728e-06
|
|
|
UBP1
|
[NCBI]
|
9.03728e-06
|
|
|
ACAD9
|
[NCBI]
|
9.03728e-06
|
|
|
NUP62
|
[NCBI]
|
9.03728e-06
|
|
|
PRAP1
|
[NCBI]
|
9.03728e-06
|
|
|
IGF2BP3
|
[NCBI]
|
9.03728e-06
|
|
|
TNIP1
|
[NCBI]
|
9.03728e-06
|
|
|
RNS4I
|
[NCBI]
|
9.03728e-06
|
|
|
SRM
|
[NCBI]
|
9.03728e-06
|
|
|
TXNRD3
|
[NCBI]
|
9.03728e-06
|
|
|
CART1
|
[NCBI]
|
9.03728e-06
|
|
|
EPC1
|
[NCBI]
|
9.03728e-06
|
|
|
ABL
|
[NCBI]
|
9.01332e-06
|
|
|
CPB2
|
[NCBI]
|
8.91618e-06
|
|
|
fructose-1,6-bisphosphatase deficiency
|
[NCBI]
|
8.85604e-06
|
|
|
GGM
|
[NCBI]
|
8.85604e-06
|
|
|
GS2
|
[NCBI]
|
8.85604e-06
|
|
|
hexokinase deficiency hemolytic anemia
|
[NCBI]
|
8.85604e-06
|
|
|
alpha-methylacetoacetic aciduria
|
[NCBI]
|
8.85604e-06
|
|
|
INAD1
|
[NCBI]
|
8.85604e-06
|
|
|
RNS
|
[NCBI]
|
8.85604e-06
|
|
|
IS
|
[NCBI]
|
8.85604e-06
|
|
|
RHN
|
[NCBI]
|
8.85604e-06
|
|
|
sc phocomelia syndrome
|
[NCBI]
|
8.85604e-06
|
|
|
AML
|
[NCBI]
|
8.85604e-06
|
|
|
PF4
|
[NCBI]
|
8.84081e-06
|
|
|
HSCR1
|
[NCBI]
|
8.81946e-06
|
|
|
VASP
|
[NCBI]
|
8.76288e-06
|
|
|
MCKD1
|
[NCBI]
|
8.69182e-06
|
|
|
PEDF
|
[NCBI]
|
8.67631e-06
|
|
|
IP
|
[NCBI]
|
8.48599e-06
|
|
|
LRP8
|
[NCBI]
|
8.47864e-06
|
|
|
CREB1
|
[NCBI]
|
8.47864e-06
|
|
|
SMA2
|
[NCBI]
|
8.44385e-06
|
|
|
SLC11A2
|
[NCBI]
|
8.42486e-06
|
|
|
BMP4
|
[NCBI]
|
8.36594e-06
|
|
|
RAMP1
|
[NCBI]
|
8.32349e-06
|
|
|
GDF15
|
[NCBI]
|
8.32349e-06
|
|
|
C5R1
|
[NCBI]
|
8.32349e-06
|
|
|
FLNB
|
[NCBI]
|
8.32349e-06
|
|
|
FYN
|
[NCBI]
|
8.32349e-06
|
|
|
EBI3
|
[NCBI]
|
8.32349e-06
|
|
|
KRT20
|
[NCBI]
|
8.29605e-06
|
|
|
NSF
|
[NCBI]
|
8.29605e-06
|
|
|
SLC6A6
|
[NCBI]
|
8.24406e-06
|
|
|
IAPP
|
[NCBI]
|
8.13158e-06
|
|
|
BCHE
|
[NCBI]
|
8.07911e-06
|
|
|
IL4
|
[NCBI]
|
7.98922e-06
|
|
|
AIRE
|
[NCBI]
|
7.83664e-06
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
7.72708e-06
|
|
|
BSG
|
[NCBI]
|
7.70929e-06
|
|
|
FGFR2
|
[NCBI]
|
7.69079e-06
|
|
|
FSHB
|
[NCBI]
|
7.65087e-06
|
|
|
SLCO2A1
|
[NCBI]
|
7.65087e-06
|
|
|
BTD
|
[NCBI]
|
7.65087e-06
|
|
|
LEPR
|
[NCBI]
|
7.53325e-06
|
|
|
SLC6A3
|
[NCBI]
|
7.49656e-06
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
7.47279e-06
|
|
|
XPG
|
[NCBI]
|
7.39978e-06
|
|
|
schwannomatosis
|
[NCBI]
|
7.39978e-06
|
|
|
LISX1
|
[NCBI]
|
7.39978e-06
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
7.39978e-06
|
|
|
argininemia
|
[NCBI]
|
7.39978e-06
|
|
|
BRIC1
|
[NCBI]
|
7.39978e-06
|
|
|
epstein syndrome
|
[NCBI]
|
7.39978e-06
|
|
|
SCN3
|
[NCBI]
|
7.39978e-06
|
|
|
LGMD2E
|
[NCBI]
|
7.39978e-06
|
|
|
stuve-wiedemann syndrome
|
[NCBI]
|
7.39978e-06
|
|
|
situs inversus viscerum
|
[NCBI]
|
7.39978e-06
|
|
|
gaucher disease, perinatal lethal
|
[NCBI]
|
7.39978e-06
|
|
|
DA1
|
[NCBI]
|
7.39978e-06
|
|
|
MTATP6
|
[NCBI]
|
7.27036e-06
|
|
|
NPS
|
[NCBI]
|
7.23485e-06
|
|
|
CSA
|
[NCBI]
|
7.23485e-06
|
|
|
CNTNAP2
|
[NCBI]
|
7.22649e-06
|
|
|
ABCA7
|
[NCBI]
|
7.22649e-06
|
|
|
PCDH12
|
[NCBI]
|
7.22649e-06
|
|
|
TROAP
|
[NCBI]
|
7.22649e-06
|
|
|
ALG3
|
[NCBI]
|
7.22649e-06
|
|
|
homeodomain-only protein
|
[NCBI]
|
7.22649e-06
|
|
|
PROKR2
|
[NCBI]
|
7.22649e-06
|
|
|
NAP1L2
|
[NCBI]
|
7.22649e-06
|
|
|
SLC28A2
|
[NCBI]
|
7.22649e-06
|
|
|
ADNP
|
[NCBI]
|
7.22649e-06
|
|
|
PRSS21
|
[NCBI]
|
7.22649e-06
|
|
|
LDB1
|
[NCBI]
|
7.22649e-06
|
|
|
MAP3K3
|
[NCBI]
|
7.22649e-06
|
|
|
PTPN5
|
[NCBI]
|
7.22649e-06
|
|
|
TBX6
|
[NCBI]
|
7.22649e-06
|
|
|
DLX4
|
[NCBI]
|
7.22649e-06
|
|
|
SCARB2
|
[NCBI]
|
7.22649e-06
|
|
|
CXORF6
|
[NCBI]
|
7.22649e-06
|
|
|
nuclear transport factor 2
|
[NCBI]
|
7.22649e-06
|
|
|
ATP6V1B2
|
[NCBI]
|
7.22649e-06
|
|
|
ES1
|
[NCBI]
|
7.22649e-06
|
|
|
HYMAI
|
[NCBI]
|
7.22649e-06
|
|
|
antigen defined by monoclonal antibody f10.44.2
|
[NCBI]
|
7.22649e-06
|
|
|
FBXW8
|
[NCBI]
|
7.22649e-06
|
|
|
CARD10
|
[NCBI]
|
7.22649e-06
|
|
|
HTR1D
|
[NCBI]
|
7.22649e-06
|
|
|
KIR2DL5
|
[NCBI]
|
7.22649e-06
|
|
|
SON
|
[NCBI]
|
7.22649e-06
|
|
|
ITGA7
|
[NCBI]
|
7.22649e-06
|
|
|
PEX26
|
[NCBI]
|
7.22649e-06
|
|
|
DSCR2
|
[NCBI]
|
7.22649e-06
|
|
|
MKL2
|
[NCBI]
|
7.22649e-06
|
|
|
ELF5
|
[NCBI]
|
7.22649e-06
|
|
|
IL1R2
|
[NCBI]
|
7.22649e-06
|
|
|
NUCB1
|
[NCBI]
|
7.22649e-06
|
|
|
AGTRAP
|
[NCBI]
|
7.22649e-06
|
|
|
CXCR7
|
[NCBI]
|
7.22649e-06
|
|
|
GPRK5
|
[NCBI]
|
7.22649e-06
|
|
|
AKAP12
|
[NCBI]
|
7.22649e-06
|
|
|
RDH10
|
[NCBI]
|
7.22649e-06
|
|
|
GPR48
|
[NCBI]
|
7.22649e-06
|
|
|
CDH12
|
[NCBI]
|
7.22649e-06
|
|
|
MMP15
|
[NCBI]
|
7.22649e-06
|
|
|
EDG7
|
[NCBI]
|
7.22649e-06
|
|
|
PMF1
|
[NCBI]
|
7.22649e-06
|
|
|
GYS2
|
[NCBI]
|
7.22649e-06
|
|
|
MYOM2
|
[NCBI]
|
7.22649e-06
|
|
|
BZRP
|
[NCBI]
|
7.22649e-06
|
|
|
CSH2
|
[NCBI]
|
7.22649e-06
|
|
|
IGKV1OR2108
|
[NCBI]
|
7.22649e-06
|
|
|
SFRP5
|
[NCBI]
|
7.22649e-06
|
|
|
SIGLEC5
|
[NCBI]
|
7.22649e-06
|
|
|
LRP4
|
[NCBI]
|
7.22649e-06
|
|
|
FLII
|
[NCBI]
|
7.22649e-06
|
|
|
GSTP1
|
[NCBI]
|
7.19501e-06
|
|
|
PTX3
|
[NCBI]
|
7.19501e-06
|
|
|
BCNS
|
[NCBI]
|
7.06602e-06
|
|
|
AQP1
|
[NCBI]
|
7.0428e-06
|
|
|
HPSE
|
[NCBI]
|
7.03942e-06
|
|
|
CCKAR
|
[NCBI]
|
7.03942e-06
|
|
|
MOS
|
[NCBI]
|
7.03942e-06
|
|
|
NTRK3
|
[NCBI]
|
7.03942e-06
|
|
|
LCAT
|
[NCBI]
|
7.03475e-06
|
|
|
hypertension, essential
|
[NCBI]
|
7.02309e-06
|
|
|
MEN1
|
[NCBI]
|
6.93378e-06
|
|
|
PPSH
|
[NCBI]
|
6.90719e-06
|
|
|
neural tube defects
|
[NCBI]
|
6.90719e-06
|
|
|
VWS
|
[NCBI]
|
6.84839e-06
|
|
|
HGFAC
|
[NCBI]
|
6.8103e-06
|
|
|
RBP4
|
[NCBI]
|
6.8103e-06
|
|
|
KDR
|
[NCBI]
|
6.81026e-06
|
|
|
PCD
|
[NCBI]
|
6.7877e-06
|
|
|
HNF1A
|
[NCBI]
|
6.78551e-06
|
|
|
PMD
|
[NCBI]
|
6.78136e-06
|
|
|
LNS
|
[NCBI]
|
6.70198e-06
|
|
|
COL7A1
|
[NCBI]
|
6.67848e-06
|
|
|
NPPA
|
[NCBI]
|
6.58703e-06
|
|
|
HEXA
|
[NCBI]
|
6.49099e-06
|
|
|
SLC26A2
|
[NCBI]
|
6.48122e-06
|
|
|
TRIM25
|
[NCBI]
|
6.48122e-06
|
|
|
TPH1
|
[NCBI]
|
6.48122e-06
|
|
|
IRF6
|
[NCBI]
|
6.48122e-06
|
|
|
THBD
|
[NCBI]
|
6.48122e-06
|
|
|
CPS1
|
[NCBI]
|
6.48122e-06
|
|
|
IGF1R
|
[NCBI]
|
6.44484e-06
|
|
|
NR1I2
|
[NCBI]
|
6.32889e-06
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
6.16739e-06
|
|
|
HSS
|
[NCBI]
|
6.16739e-06
|
|
|
corpus callosum, agenesis of
|
[NCBI]
|
6.16739e-06
|
|
|
gracile syndrome
|
[NCBI]
|
6.16739e-06
|
|
|
XPV
|
[NCBI]
|
6.16739e-06
|
|
|
feingold syndrome
|
[NCBI]
|
6.16739e-06
|
|
|
myeloma, multiple
|
[NCBI]
|
6.16739e-06
|
|
|
kniest dysplasia
|
[NCBI]
|
6.16739e-06
|
|
|
HTX1
|
[NCBI]
|
6.16739e-06
|
|
|
WS3
|
[NCBI]
|
6.16739e-06
|
|
|
coloboma, ocular
|
[NCBI]
|
6.16739e-06
|
|
|
UCP3
|
[NCBI]
|
6.05448e-06
|
|
|
ANGPTL4
|
[NCBI]
|
5.96977e-06
|
|
|
NR5A2
|
[NCBI]
|
5.96977e-06
|
|
|
RAD51
|
[NCBI]
|
5.96977e-06
|
|
|
PEG3
|
[NCBI]
|
5.96977e-06
|
|
|
KLF9
|
[NCBI]
|
5.93406e-06
|
|
|
RPS27A
|
[NCBI]
|
5.93406e-06
|
|
|
FANCF
|
[NCBI]
|
5.93406e-06
|
|
|
PFKFB3
|
[NCBI]
|
5.93406e-06
|
|
|
b-cell rag-associated gene
|
[NCBI]
|
5.93406e-06
|
|
|
TRO
|
[NCBI]
|
5.93406e-06
|
|
|
GLMN
|
[NCBI]
|
5.93406e-06
|
|
|
CFDP1
|
[NCBI]
|
5.93406e-06
|
|
|
GLS
|
[NCBI]
|
5.93406e-06
|
|
|
GIPC1
|
[NCBI]
|
5.93406e-06
|
|
|
VIPR1
|
[NCBI]
|
5.93406e-06
|
|
|
PPP2R1B
|
[NCBI]
|
5.93406e-06
|
|
|
TECTB
|
[NCBI]
|
5.93406e-06
|
|
|
EDG2
|
[NCBI]
|
5.93406e-06
|
|
|
BRSK2
|
[NCBI]
|
5.93406e-06
|
|
|
JARID1A
|
[NCBI]
|
5.93406e-06
|
|
|
ACADSB
|
[NCBI]
|
5.93406e-06
|
|
|
CCNE2
|
[NCBI]
|
5.93406e-06
|
|
|
PTPN2
|
[NCBI]
|
5.93406e-06
|
|
|
SCN11A
|
[NCBI]
|
5.93406e-06
|
|
|
NDUFV1
|
[NCBI]
|
5.93406e-06
|
|
|
ABCA12
|
[NCBI]
|
5.93406e-06
|
|
|
BAPX1
|
[NCBI]
|
5.93406e-06
|
|
|
FADS1
|
[NCBI]
|
5.93406e-06
|
|
|
CPA4
|
[NCBI]
|
5.93406e-06
|
|
|
RAB3GAP1
|
[NCBI]
|
5.93406e-06
|
|
|
FKBP4
|
[NCBI]
|
5.93406e-06
|
|
|
EIF2AK4
|
[NCBI]
|
5.93406e-06
|
|
|
PTGES3
|
[NCBI]
|
5.93406e-06
|
|
|
STE
|
[NCBI]
|
5.93406e-06
|
|
|
KLC1
|
[NCBI]
|
5.93406e-06
|
|
|
CAPG
|
[NCBI]
|
5.93406e-06
|
|
|
FAM20C
|
[NCBI]
|
5.93406e-06
|
|
|
YWHAG
|
[NCBI]
|
5.93406e-06
|
|
|
TRIM21
|
[NCBI]
|
5.93406e-06
|
|
|
ADRA2B
|
[NCBI]
|
5.93406e-06
|
|
|
GDF9
|
[NCBI]
|
5.93406e-06
|
|
|
CALB3
|
[NCBI]
|
5.93406e-06
|
|
|
COL14A1
|
[NCBI]
|
5.93406e-06
|
|
|
ALDH1B1
|
[NCBI]
|
5.93406e-06
|
|
|
FBXW11
|
[NCBI]
|
5.93406e-06
|
|
|
FBXO6
|
[NCBI]
|
5.93406e-06
|
|
|
ROCK2
|
[NCBI]
|
5.93406e-06
|
|
|
TNS1
|
[NCBI]
|
5.93406e-06
|
|
|
TXN2
|
[NCBI]
|
5.93406e-06
|
|
|
CRK
|
[NCBI]
|
5.93406e-06
|
|
|
SIM1
|
[NCBI]
|
5.93406e-06
|
|
|
ENDOG
|
[NCBI]
|
5.93406e-06
|
|
|
CXXC1
|
[NCBI]
|
5.93406e-06
|
|
|
TOP3B
|
[NCBI]
|
5.93406e-06
|
|
|
ST3GAL2
|
[NCBI]
|
5.93406e-06
|
|
|
YWHAH
|
[NCBI]
|
5.93406e-06
|
|
|
ZAR1
|
[NCBI]
|
5.93406e-06
|
|
|
ITGA6
|
[NCBI]
|
5.93406e-06
|
|
|
SHOX2
|
[NCBI]
|
5.93406e-06
|
|
|
CUL7
|
[NCBI]
|
5.93406e-06
|
|
|
MCHR2
|
[NCBI]
|
5.93406e-06
|
|
|
PHLDA2
|
[NCBI]
|
5.93406e-06
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
5.84359e-06
|
|
|
GHRH
|
[NCBI]
|
5.83036e-06
|
|
|
FA
|
[NCBI]
|
5.82144e-06
|
|
|
KITLG
|
[NCBI]
|
5.81888e-06
|
|
|
VHL
|
[NCBI]
|
5.76716e-06
|
|
|
CLS
|
[NCBI]
|
5.67992e-06
|
|
|
F13A1
|
[NCBI]
|
5.61575e-06
|
|
|
HBA1
|
[NCBI]
|
5.54502e-06
|
|
|
IL6ST
|
[NCBI]
|
5.49971e-06
|
|
|
GLDC
|
[NCBI]
|
5.49971e-06
|
|
|
GLB1
|
[NCBI]
|
5.4524e-06
|
|
|
PSEN1
|
[NCBI]
|
5.39399e-06
|
|
|
GIP
|
[NCBI]
|
5.35013e-06
|
|
|
HGF
|
[NCBI]
|
5.32979e-06
|
|
|
MHS1
|
[NCBI]
|
5.30577e-06
|
|
|
CCM
|
[NCBI]
|
5.30577e-06
|
|
|
AN2
|
[NCBI]
|
5.30577e-06
|
|
|
WS1
|
[NCBI]
|
5.26587e-06
|
|
|
CCND1
|
[NCBI]
|
5.22815e-06
|
|
|
carbamoyl phosphate synthetase i deficiency, hyperammonemia due to
|
[NCBI]
|
5.11799e-06
|
|
|
RHS
|
[NCBI]
|
5.11799e-06
|
|
|
HPE2
|
[NCBI]
|
5.11799e-06
|
|
|
XPF
|
[NCBI]
|
5.11799e-06
|
|
|
HOMG
|
[NCBI]
|
5.11799e-06
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
5.11799e-06
|
|
|
HHS
|
[NCBI]
|
5.11799e-06
|
|
|
SMDP1
|
[NCBI]
|
5.11799e-06
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
5.11799e-06
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
5.11799e-06
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
5.11799e-06
|
|
|
SNDI
|
[NCBI]
|
5.11799e-06
|
|
|
SPINK1
|
[NCBI]
|
5.11132e-06
|
|
|
CRHR1
|
[NCBI]
|
5.06655e-06
|
|
|
FUT2
|
[NCBI]
|
5.06655e-06
|
|
|
RPS6KA1
|
[NCBI]
|
5.06655e-06
|
|
|
COL1A1
|
[NCBI]
|
5.0604e-06
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
5.00677e-06
|
|
|
PLTP
|
[NCBI]
|
4.97918e-06
|
|
|
GCM1
|
[NCBI]
|
4.94693e-06
|
|
|
MESP2
|
[NCBI]
|
4.94693e-06
|
|
|
MAFK
|
[NCBI]
|
4.94693e-06
|
|
|
PLK2
|
[NCBI]
|
4.94693e-06
|
|
|
PI9
|
[NCBI]
|
4.94693e-06
|
|
|
KCNK2
|
[NCBI]
|
4.94693e-06
|
|
|
LTB
|
[NCBI]
|
4.94693e-06
|
|
|
PHB2
|
[NCBI]
|
4.94693e-06
|
|
|
LHX9
|
[NCBI]
|
4.94693e-06
|
|
|
KCNN3
|
[NCBI]
|
4.94693e-06
|
|
|
IFI6
|
[NCBI]
|
4.94693e-06
|
|
|
SELPLG
|
[NCBI]
|
4.94693e-06
|
|
|
NHEJ1
|
[NCBI]
|
4.94693e-06
|
|
|
SRG1
|
[NCBI]
|
4.94693e-06
|
|
|
FOXF2
|
[NCBI]
|
4.94693e-06
|
|
|
PLUNC
|
[NCBI]
|
4.94693e-06
|
|
|
SLC22A3
|
[NCBI]
|
4.94693e-06
|
|
|
DLX3
|
[NCBI]
|
4.94693e-06
|
|
|
NTF5
|
[NCBI]
|
4.94693e-06
|
|
|
ATOX1
|
[NCBI]
|
4.94693e-06
|
|
|
GATM
|
[NCBI]
|
4.94693e-06
|
|
|
TACR2
|
[NCBI]
|
4.94693e-06
|
|
|
CMA1
|
[NCBI]
|
4.94693e-06
|
|
|
STX11
|
[NCBI]
|
4.94693e-06
|
|
|
FCGR1A
|
[NCBI]
|
4.94693e-06
|
|
|
ARL4
|
[NCBI]
|
4.94693e-06
|
|
|
CTSF
|
[NCBI]
|
4.94693e-06
|
|
|
IFITM1
|
[NCBI]
|
4.94693e-06
|
|
|
SLC29A4
|
[NCBI]
|
4.94693e-06
|
|
|
LALBA
|
[NCBI]
|
4.94693e-06
|
|
|
POU4F3
|
[NCBI]
|
4.94693e-06
|
|
|
ARID4A
|
[NCBI]
|
4.94693e-06
|
|
|
TXNRD1
|
[NCBI]
|
4.94693e-06
|
|
|
STMN2
|
[NCBI]
|
4.94693e-06
|
|
|
FTSJ1
|
[NCBI]
|
4.94693e-06
|
|
|
GPRK6
|
[NCBI]
|
4.94693e-06
|
|
|
switch-associated protein 70
|
[NCBI]
|
4.94693e-06
|
|
|
TBX19
|
[NCBI]
|
4.94693e-06
|
|
|
GSCL
|
[NCBI]
|
4.94693e-06
|
|
|
FANCM
|
[NCBI]
|
4.94693e-06
|
|
|
VGF
|
[NCBI]
|
4.94693e-06
|
|
|
LUM
|
[NCBI]
|
4.94693e-06
|
|
|
PTPRE
|
[NCBI]
|
4.94693e-06
|
|
|
COTL1
|
[NCBI]
|
4.94693e-06
|
|
|
GCSH
|
[NCBI]
|
4.94693e-06
|
|
|
TNNT3
|
[NCBI]
|
4.94693e-06
|
|
|
POU4F1
|
[NCBI]
|
4.94693e-06
|
|
|
ARG2
|
[NCBI]
|
4.94693e-06
|
|
|
P2RY6
|
[NCBI]
|
4.94693e-06
|
|
|
PFTK1
|
[NCBI]
|
4.94693e-06
|
|
|
P2RY1
|
[NCBI]
|
4.94693e-06
|
|
|
FDXR
|
[NCBI]
|
4.94693e-06
|
|
|
CHAD
|
[NCBI]
|
4.94693e-06
|
|
|
HSD17B2
|
[NCBI]
|
4.94693e-06
|
|
|
PHF9
|
[NCBI]
|
4.94693e-06
|
|
|
obesity
|
[NCBI]
|
4.93981e-06
|
|
|
RB1
|
[NCBI]
|
4.92425e-06
|
|
|
PAI1
|
[NCBI]
|
4.86758e-06
|
|
|
PTHR1
|
[NCBI]
|
4.86758e-06
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
4.83769e-06
|
|
|
ACADM
|
[NCBI]
|
4.75229e-06
|
|
|
GALK1
|
[NCBI]
|
4.66649e-06
|
|
|
SMAD2
|
[NCBI]
|
4.66649e-06
|
|
|
MME
|
[NCBI]
|
4.66649e-06
|
|
|
HSD11B1
|
[NCBI]
|
4.66649e-06
|
|
|
CSF1
|
[NCBI]
|
4.66649e-06
|
|
|
BMP1
|
[NCBI]
|
4.66649e-06
|
|
|
phenylketonuria ii
|
[NCBI]
|
4.66649e-06
|
|
|
IHH
|
[NCBI]
|
4.63717e-06
|
|
|
GPI
|
[NCBI]
|
4.60765e-06
|
|
|
HBG1
|
[NCBI]
|
4.59615e-06
|
|
|
BAX
|
[NCBI]
|
4.5957e-06
|
|
|
BGN
|
[NCBI]
|
4.5957e-06
|
|
|
BRCA1
|
[NCBI]
|
4.58373e-06
|
|
|
glioma of brain, familial
|
[NCBI]
|
4.58238e-06
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
4.58238e-06
|
|
|
SLC2A4
|
[NCBI]
|
4.4756e-06
|
|
|
IL6
|
[NCBI]
|
4.37695e-06
|
|
|
FANCC
|
[NCBI]
|
4.33653e-06
|
|
|
CTGF
|
[NCBI]
|
4.32799e-06
|
|
|
CLN3
|
[NCBI]
|
4.29628e-06
|
|
|
SLC2A1
|
[NCBI]
|
4.29628e-06
|
|
|
PI3
|
[NCBI]
|
4.29628e-06
|
|
|
IGF2
|
[NCBI]
|
4.28062e-06
|
|
|
TPO
|
[NCBI]
|
4.27992e-06
|
|
|
ARSA
|
[NCBI]
|
4.24675e-06
|
|
|
cyclic hematopoiesis
|
[NCBI]
|
4.22094e-06
|
|
|
chromosome 18q deletion syndrome
|
[NCBI]
|
4.22094e-06
|
|
|
ACCPN
|
[NCBI]
|
4.22094e-06
|
|
|
cutis laxa, autosomal recessive, type i
|
[NCBI]
|
4.22094e-06
|
|
|
XPD
|
[NCBI]
|
4.22094e-06
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
4.22094e-06
|
|
|
DSMA1
|
[NCBI]
|
4.22094e-06
|
|
|
crouzon syndrome
|
[NCBI]
|
4.22094e-06
|
|
|
GRTH
|
[NCBI]
|
4.22094e-06
|
|
|
papillorenal syndrome
|
[NCBI]
|
4.22094e-06
|
|
|
septooptic dysplasia
|
[NCBI]
|
4.22094e-06
|
|
|
LIPG
|
[NCBI]
|
4.16154e-06
|
|
|
CD83
|
[NCBI]
|
4.16154e-06
|
|
|
SPHK2
|
[NCBI]
|
4.16154e-06
|
|
|
CHD7
|
[NCBI]
|
4.16154e-06
|
|
|
CDC5L
|
[NCBI]
|
4.16154e-06
|
|
|
TXNRD2
|
[NCBI]
|
4.16154e-06
|
|
|
ABCA3
|
[NCBI]
|
4.16154e-06
|
|
|
NPR3
|
[NCBI]
|
4.16154e-06
|
|
|
JAG2
|
[NCBI]
|
4.16154e-06
|
|
|
NEGF2
|
[NCBI]
|
4.16154e-06
|
|
|
ITM2A
|
[NCBI]
|
4.16154e-06
|
|
|
AKR1C3
|
[NCBI]
|
4.16154e-06
|
|
|
GBX2
|
[NCBI]
|
4.16154e-06
|
|
|
SUFU
|
[NCBI]
|
4.16154e-06
|
|
|
UBE2D1
|
[NCBI]
|
4.16154e-06
|
|
|
PDLIM3
|
[NCBI]
|
4.16154e-06
|
|
|
TRA1
|
[NCBI]
|
4.16154e-06
|
|
|
LMNB2
|
[NCBI]
|
4.16154e-06
|
|
|
B3GALNT1
|
[NCBI]
|
4.16154e-06
|
|
|
PTPN13
|
[NCBI]
|
4.16154e-06
|
|
|
CRYM
|
[NCBI]
|
4.16154e-06
|
|
|
SATB2
|
[NCBI]
|
4.16154e-06
|
|
|
TRPV5
|
[NCBI]
|
4.16154e-06
|
|
|
HAND1
|
[NCBI]
|
4.16154e-06
|
|
|
MAFG
|
[NCBI]
|
4.16154e-06
|
|
|
LHX2
|
[NCBI]
|
4.16154e-06
|
|
|
FOSB
|
[NCBI]
|
4.16154e-06
|
|
|
NKX2-2
|
[NCBI]
|
4.16154e-06
|
|
|
DGCR14
|
[NCBI]
|
4.16154e-06
|
|
|
TICAM1
|
[NCBI]
|
4.16154e-06
|
|
|
IL5RA
|
[NCBI]
|
4.16154e-06
|
|
|
FGD4
|
[NCBI]
|
4.16154e-06
|
|
|
CALB1
|
[NCBI]
|
4.16154e-06
|
|
|
P4HA1
|
[NCBI]
|
4.16154e-06
|
|
|
CDKN2C
|
[NCBI]
|
4.16154e-06
|
|
|
ESCO2
|
[NCBI]
|
4.16154e-06
|
|
|
P2RX1
|
[NCBI]
|
4.16154e-06
|
|
|
DLAT
|
[NCBI]
|
4.16154e-06
|
|
|
KCND3
|
[NCBI]
|
4.16154e-06
|
|
|
GADD45G
|
[NCBI]
|
4.16154e-06
|
|
|
AKR1C1
|
[NCBI]
|
4.16154e-06
|
|
|
MSLN
|
[NCBI]
|
4.16154e-06
|
|
|
FBXO2
|
[NCBI]
|
4.16154e-06
|
|
|
CKB
|
[NCBI]
|
4.16154e-06
|
|
|
LOXL2
|
[NCBI]
|
4.16154e-06
|
|
|
PCTP
|
[NCBI]
|
4.16154e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
4.08942e-06
|
|
|
ATF2
|
[NCBI]
|
4.08942e-06
|
|
|
EDNRB
|
[NCBI]
|
4.08942e-06
|
|
|
INS
|
[NCBI]
|
4.04703e-06
|
|
|
NR0B2
|
[NCBI]
|
3.98261e-06
|
|
|
DBH
|
[NCBI]
|
3.95315e-06
|
|
|
IFNAR1
|
[NCBI]
|
3.95315e-06
|
|
|
PLOD1
|
[NCBI]
|
3.95315e-06
|
|
|
SYP
|
[NCBI]
|
3.95315e-06
|
|
|
HAS2
|
[NCBI]
|
3.95315e-06
|
|
|
LWD
|
[NCBI]
|
3.8946e-06
|
|
|
GJB2
|
[NCBI]
|
3.87e-06
|
|
|
STC1
|
[NCBI]
|
3.76607e-06
|
|
|
TTR
|
[NCBI]
|
3.74226e-06
|
|
|
UBTF
|
[NCBI]
|
3.72276e-06
|
|
|
UBE3A
|
[NCBI]
|
3.63469e-06
|
|
|
NRTN
|
[NCBI]
|
3.63469e-06
|
|
|
SLC5A7
|
[NCBI]
|
3.63469e-06
|
|
|
LAMB3
|
[NCBI]
|
3.63469e-06
|
|
|
AQP2
|
[NCBI]
|
3.59452e-06
|
|
|
sotos syndrome
|
[NCBI]
|
3.56504e-06
|
|
|
SCIDX1
|
[NCBI]
|
3.56504e-06
|
|
|
HDAC1
|
[NCBI]
|
3.56037e-06
|
|
|
JAK2
|
[NCBI]
|
3.53851e-06
|
|
|
GC
|
[NCBI]
|
3.5223e-06
|
|
|
ADAM9
|
[NCBI]
|
3.51952e-06
|
|
|
LRPAP1
|
[NCBI]
|
3.51952e-06
|
|
|
ADCYAP1R1
|
[NCBI]
|
3.51952e-06
|
|
|
LAMP1
|
[NCBI]
|
3.51952e-06
|
|
|
PROX1
|
[NCBI]
|
3.51952e-06
|
|
|
ADRA2A
|
[NCBI]
|
3.51952e-06
|
|
|
HNRPA1
|
[NCBI]
|
3.51952e-06
|
|
|
AMOT
|
[NCBI]
|
3.51952e-06
|
|
|
NT5C
|
[NCBI]
|
3.51952e-06
|
|
|
DDX6
|
[NCBI]
|
3.51952e-06
|
|
|
PAI2
|
[NCBI]
|
3.51952e-06
|
|
|
DSC3
|
[NCBI]
|
3.51952e-06
|
|
|
PTGFR
|
[NCBI]
|
3.51952e-06
|
|
|
S100A4
|
[NCBI]
|
3.51952e-06
|
|
|
DNASE2
|
[NCBI]
|
3.51952e-06
|
|
|
RBX1
|
[NCBI]
|
3.51952e-06
|
|
|
AKR1C4
|
[NCBI]
|
3.51952e-06
|
|
|
AKAP9
|
[NCBI]
|
3.51952e-06
|
|
|
ACP2
|
[NCBI]
|
3.51952e-06
|
|
|
GRIA4
|
[NCBI]
|
3.51952e-06
|
|
|
SAT1
|
[NCBI]
|
3.51952e-06
|
|
|
NR2F2
|
[NCBI]
|
3.51952e-06
|
|
|
AURKC
|
[NCBI]
|
3.51952e-06
|
|
|
PSG4
|
[NCBI]
|
3.51952e-06
|
|
|
HSPA2
|
[NCBI]
|
3.51952e-06
|
|
|
CDC18L
|
[NCBI]
|
3.51952e-06
|
|
|
GJC1
|
[NCBI]
|
3.51952e-06
|
|
|
PSG7
|
[NCBI]
|
3.51952e-06
|
|
|
PSG9
|
[NCBI]
|
3.51952e-06
|
|
|
ISL1
|
[NCBI]
|
3.51952e-06
|
|
|
DNAJA3
|
[NCBI]
|
3.51952e-06
|
|
|
EDG3
|
[NCBI]
|
3.51952e-06
|
|
|
IFNGR2
|
[NCBI]
|
3.51952e-06
|
|
|
PSG5
|
[NCBI]
|
3.51952e-06
|
|
|
LGR8
|
[NCBI]
|
3.51952e-06
|
|
|
COPS5
|
[NCBI]
|
3.51952e-06
|
|
|
APLN
|
[NCBI]
|
3.51952e-06
|
|
|
SLC23A2
|
[NCBI]
|
3.51952e-06
|
|
|
OGFR
|
[NCBI]
|
3.51952e-06
|
|
|
LOXL1
|
[NCBI]
|
3.51952e-06
|
|
|
NEUROG1
|
[NCBI]
|
3.51952e-06
|
|
|
PSG10
|
[NCBI]
|
3.51952e-06
|
|
|
PSG8
|
[NCBI]
|
3.51952e-06
|
|
|
PSG11
|
[NCBI]
|
3.51952e-06
|
|
|
SMARCA5
|
[NCBI]
|
3.51952e-06
|
|
|
PSG6
|
[NCBI]
|
3.51952e-06
|
|
|
FANCE
|
[NCBI]
|
3.51952e-06
|
|
|
DBN1
|
[NCBI]
|
3.51952e-06
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
3.50961e-06
|
|
|
NRG1
|
[NCBI]
|
3.45621e-06
|
|
|
mucopolysaccharidosis type iiic
|
[NCBI]
|
3.45276e-06
|
|
|
ISS
|
[NCBI]
|
3.45276e-06
|
|
|
anemia, dyserythropoietic congenital, type i
|
[NCBI]
|
3.45276e-06
|
|
|
coenzyme q10 deficiency
|
[NCBI]
|
3.45276e-06
|
|
|
methionine adenosyltransferase deficiency
|
[NCBI]
|
3.45276e-06
|
|
|
mucolipidosis iiia
|
[NCBI]
|
3.45276e-06
|
|
|
LQT3
|
[NCBI]
|
3.45276e-06
|
|
|
PPS
|
[NCBI]
|
3.45276e-06
|
|
|
tetralogy of fallot
|
[NCBI]
|
3.45276e-06
|
|
|
OPD2
|
[NCBI]
|
3.45276e-06
|
|
|
langer mesomelic dysplasia
|
[NCBI]
|
3.45276e-06
|
|
|
CTNNB1
|
[NCBI]
|
3.34157e-06
|
|
|
PON1
|
[NCBI]
|
3.34091e-06
|
|
|
HSR
|
[NCBI]
|
3.33878e-06
|
|
|
LDHA
|
[NCBI]
|
3.33878e-06
|
|
|
COL4A1
|
[NCBI]
|
3.33878e-06
|
|
|
EDA
|
[NCBI]
|
3.33878e-06
|
|
|
SPS
|
[NCBI]
|
3.33086e-06
|
|
|
ASS
|
[NCBI]
|
3.32278e-06
|
|
|
PG
|
[NCBI]
|
3.2508e-06
|
|
|
GPT
|
[NCBI]
|
3.21693e-06
|
|
|
BLM
|
[NCBI]
|
3.18318e-06
|
|
|
LS
|
[NCBI]
|
3.18318e-06
|
|
|
UCP1
|
[NCBI]
|
3.1628e-06
|
|
|
LIPC
|
[NCBI]
|
3.09355e-06
|
|
|
NOTCH1
|
[NCBI]
|
3.09355e-06
|
|
|
CD36
|
[NCBI]
|
3.09355e-06
|
|
|
LPL
|
[NCBI]
|
3.08884e-06
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
3.08747e-06
|
|
|
SJS1
|
[NCBI]
|
3.08747e-06
|
|
|
ALCAM
|
[NCBI]
|
3.06358e-06
|
|
|
TGM1
|
[NCBI]
|
3.06358e-06
|
|
|
SLC12A3
|
[NCBI]
|
3.06358e-06
|
|
|
AKR1B1
|
[NCBI]
|
3.03433e-06
|
|
|
MAS1
|
[NCBI]
|
2.98471e-06
|
|
|
PTGES
|
[NCBI]
|
2.98471e-06
|
|
|
FGF14
|
[NCBI]
|
2.98471e-06
|
|
|
POR
|
[NCBI]
|
2.98471e-06
|
|
|
NEUROG3
|
[NCBI]
|
2.98471e-06
|
|
|
SNAI2
|
[NCBI]
|
2.98471e-06
|
|
|
NUMBL
|
[NCBI]
|
2.98471e-06
|
|
|
SLC2A8
|
[NCBI]
|
2.98471e-06
|
|
|
EDNRA
|
[NCBI]
|
2.98471e-06
|
|
|
PKP2
|
[NCBI]
|
2.98471e-06
|
|
|
RPL19
|
[NCBI]
|
2.98471e-06
|
|
|
BCKDHB
|
[NCBI]
|
2.98471e-06
|
|
|
DPEP1
|
[NCBI]
|
2.98471e-06
|
|
|
ARSE
|
[NCBI]
|
2.98471e-06
|
|
|
MKKS
|
[NCBI]
|
2.98471e-06
|
|
|
SLC30A4
|
[NCBI]
|
2.98471e-06
|
|
|
NOTCH4
|
[NCBI]
|
2.98471e-06
|
|
|
HIST1H3C
|
[NCBI]
|
2.98471e-06
|
|
|
LMO4
|
[NCBI]
|
2.98471e-06
|
|
|
AKR1C2
|
[NCBI]
|
2.98471e-06
|
|
|
ACVR1C
|
[NCBI]
|
2.98471e-06
|
|
|
HCF2
|
[NCBI]
|
2.98471e-06
|
|
|
AOAH
|
[NCBI]
|
2.98471e-06
|
|
|
PEX5
|
[NCBI]
|
2.98471e-06
|
|
|
GART
|
[NCBI]
|
2.98471e-06
|
|
|
SCG2
|
[NCBI]
|
2.98471e-06
|
|
|
PEG10
|
[NCBI]
|
2.98471e-06
|
|
|
IGFBP5
|
[NCBI]
|
2.98471e-06
|
|
|
TOP3A
|
[NCBI]
|
2.98471e-06
|
|
|
GPR98
|
[NCBI]
|
2.98471e-06
|
|
|
CD9
|
[NCBI]
|
2.98471e-06
|
|
|
IGFBP2
|
[NCBI]
|
2.98471e-06
|
|
|
RAD21
|
[NCBI]
|
2.98471e-06
|
|
|
CARD11
|
[NCBI]
|
2.98471e-06
|
|
|
SEMA5A
|
[NCBI]
|
2.98471e-06
|
|
|
AK3
|
[NCBI]
|
2.98471e-06
|
|
|
NFE2L2
|
[NCBI]
|
2.98471e-06
|
|
|
SFRS1
|
[NCBI]
|
2.98471e-06
|
|
|
BCAT1
|
[NCBI]
|
2.98471e-06
|
|
|
TFAP2C
|
[NCBI]
|
2.98471e-06
|
|
|
ACVR2
|
[NCBI]
|
2.98471e-06
|
|
|
BCL2
|
[NCBI]
|
2.97148e-06
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
2.93678e-06
|
|
|
LI1
|
[NCBI]
|
2.93678e-06
|
|
|
TG
|
[NCBI]
|
2.92677e-06
|
|
|
MAG
|
[NCBI]
|
2.9197e-06
|
|
|
AHO
|
[NCBI]
|
2.90595e-06
|
|
|
CF
|
[NCBI]
|
2.87069e-06
|
|
|
IRS1
|
[NCBI]
|
2.85076e-06
|
|
|
PWS
|
[NCBI]
|
2.84882e-06
|
|
|
myasthenic syndrome, congenital, associated with episodic apnea
|
[NCBI]
|
2.79496e-06
|
|
|
CDG2C
|
[NCBI]
|
2.79496e-06
|
|
|
chromosome 5q deletion syndrome
|
[NCBI]
|
2.79496e-06
|
|
|
UMS
|
[NCBI]
|
2.79496e-06
|
|
|
lymphedema-distichiasis syndrome
|
[NCBI]
|
2.79496e-06
|
|
|
muckle-wells syndrome
|
[NCBI]
|
2.79496e-06
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
[NCBI]
|
2.79496e-06
|
|
|
CFTD
|
[NCBI]
|
2.79496e-06
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
2.79496e-06
|
|
|
MTS
|
[NCBI]
|
2.79496e-06
|
|
|
CMTC
|
[NCBI]
|
2.79496e-06
|
|
|
F3
|
[NCBI]
|
2.78391e-06
|
|
|
IDE
|
[NCBI]
|
2.75515e-06
|
|
|
SDC2
|
[NCBI]
|
2.70394e-06
|
|
|
FIH
|
[NCBI]
|
2.70005e-06
|
|
|
SMA3
|
[NCBI]
|
2.70005e-06
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
2.70005e-06
|
|
|
HD
|
[NCBI]
|
2.67674e-06
|
|
|
CCD
|
[NCBI]
|
2.67632e-06
|
|
|
NR5A1
|
[NCBI]
|
2.60188e-06
|
|
|
AIC
|
[NCBI]
|
2.57616e-06
|
|
|
CMH
|
[NCBI]
|
2.56277e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
2.56277e-06
|
|
|
FBXW7
|
[NCBI]
|
2.53312e-06
|
|
|
GSTT1
|
[NCBI]
|
2.53312e-06
|
|
|
PTPRF
|
[NCBI]
|
2.53312e-06
|
|
|
CDH3
|
[NCBI]
|
2.53312e-06
|
|
|
KIF3A
|
[NCBI]
|
2.53312e-06
|
|
|
DSCAM
|
[NCBI]
|
2.53312e-06
|
|
|
NES
|
[NCBI]
|
2.53312e-06
|
|
|
PRKG1
|
[NCBI]
|
2.53312e-06
|
|
|
AMT
|
[NCBI]
|
2.53312e-06
|
|
|
CUL3
|
[NCBI]
|
2.53312e-06
|
|
|
IGKV
|
[NCBI]
|
2.53312e-06
|
|
|
PBK
|
[NCBI]
|
2.53312e-06
|
|
|
GAS1
|
[NCBI]
|
2.53312e-06
|
|
|
LEFTY2
|
[NCBI]
|
2.53312e-06
|
|
|
TMSB4X
|
[NCBI]
|
2.53312e-06
|
|
|
GPX4
|
[NCBI]
|
2.53312e-06
|
|
|
SYCP3
|
[NCBI]
|
2.53312e-06
|
|
|
CXCL11
|
[NCBI]
|
2.53312e-06
|
|
|
RECQL4
|
[NCBI]
|
2.53312e-06
|
|
|
FOXN1
|
[NCBI]
|
2.53312e-06
|
|
|
TUB
|
[NCBI]
|
2.53312e-06
|
|
|
HAL
|
[NCBI]
|
2.53312e-06
|
|
|
RB1CC1
|
[NCBI]
|
2.53312e-06
|
|
|
WNT7A
|
[NCBI]
|
2.53312e-06
|
|
|
TTC10
|
[NCBI]
|
2.53312e-06
|
|
|
LGALS1
|
[NCBI]
|
2.53312e-06
|
|
|
NCAM1
|
[NCBI]
|
2.53312e-06
|
|
|
KLF1
|
[NCBI]
|
2.4971e-06
|
|
|
HNF4A
|
[NCBI]
|
2.4971e-06
|
|
|
MAP2
|
[NCBI]
|
2.49315e-06
|
|
|
DDC
|
[NCBI]
|
2.48512e-06
|
|
|
TCF7L2
|
[NCBI]
|
2.48276e-06
|
|
|
DMPK
|
[NCBI]
|
2.48276e-06
|
|
|
breast cancer
|
[NCBI]
|
2.45421e-06
|
|
|
CDH1
|
[NCBI]
|
2.3822e-06
|
|
|
ASL
|
[NCBI]
|
2.3822e-06
|
|
|
BMD
|
[NCBI]
|
2.35299e-06
|
|
|
INPP5D
|
[NCBI]
|
2.34688e-06
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
2.34688e-06
|
|
|
TIMP3
|
[NCBI]
|
2.34688e-06
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
2.34539e-06
|
|
|
BRCA2
|
[NCBI]
|
2.32488e-06
|
|
|
SDS
|
[NCBI]
|
2.23984e-06
|
|
|
HDC
|
[NCBI]
|
2.23661e-06
|
|
|
PFM
|
[NCBI]
|
2.23281e-06
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
2.23281e-06
|
|
|
ehlers-danlos syndrome, type vi
|
[NCBI]
|
2.23281e-06
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
2.23281e-06
|
|
|
coumarin resistance
|
[NCBI]
|
2.23281e-06
|
|
|
hartnup disorder
|
[NCBI]
|
2.23281e-06
|
|
|
AFD1
|
[NCBI]
|
2.23281e-06
|
|
|
alexander disease
|
[NCBI]
|
2.23281e-06
|
|
|
GCK
|
[NCBI]
|
2.20839e-06
|
|
|
CES
|
[NCBI]
|
2.19174e-06
|
|
|
COL3A1
|
[NCBI]
|
2.16801e-06
|
|
|
FOXF1
|
[NCBI]
|
2.148e-06
|
|
|
CSF2RA
|
[NCBI]
|
2.148e-06
|
|
|
GRIA3
|
[NCBI]
|
2.148e-06
|
|
|
HOXA1
|
[NCBI]
|
2.148e-06
|
|
|
CCL5
|
[NCBI]
|
2.148e-06
|
|
|
COL15A1
|
[NCBI]
|
2.148e-06
|
|
|
HPR
|
[NCBI]
|
2.148e-06
|
|
|
HESX1
|
[NCBI]
|
2.148e-06
|
|
|
HOXA13
|
[NCBI]
|
2.148e-06
|
|
|
TGIF
|
[NCBI]
|
2.148e-06
|
|
|
PDCD1LG1
|
[NCBI]
|
2.148e-06
|
|
|
IGHM
|
[NCBI]
|
2.148e-06
|
|
|
ST8SIA4
|
[NCBI]
|
2.148e-06
|
|
|
RIPK2
|
[NCBI]
|
2.148e-06
|
|
|
PRMT1
|
[NCBI]
|
2.148e-06
|
|
|
LAMA3
|
[NCBI]
|
2.148e-06
|
|
|
BARD1
|
[NCBI]
|
2.148e-06
|
|
|
PTPRO
|
[NCBI]
|
2.148e-06
|
|
|
AMN
|
[NCBI]
|
2.148e-06
|
|
|
MYT1
|
[NCBI]
|
2.148e-06
|
|
|
SEMA3B
|
[NCBI]
|
2.148e-06
|
|
|
CCNB1
|
[NCBI]
|
2.148e-06
|
|
|
SLC22A2
|
[NCBI]
|
2.148e-06
|
|
|
MTNR1A
|
[NCBI]
|
2.148e-06
|
|
|
LAMC1
|
[NCBI]
|
2.148e-06
|
|
|
FMOD
|
[NCBI]
|
2.148e-06
|
|
|
CFD
|
[NCBI]
|
2.148e-06
|
|
|
HK2
|
[NCBI]
|
2.148e-06
|
|
|
MTTI
|
[NCBI]
|
2.148e-06
|
|
|
HTR1B
|
[NCBI]
|
2.148e-06
|
|
|
BUB1B
|
[NCBI]
|
2.148e-06
|
|
|
LAMB1
|
[NCBI]
|
2.148e-06
|
|
|
POMGNT1
|
[NCBI]
|
2.148e-06
|
|
|
HLA-DQA1
|
[NCBI]
|
2.13998e-06
|
|
|
APEX
|
[NCBI]
|
2.13998e-06
|
|
|
COL17A1
|
[NCBI]
|
2.13998e-06
|
|
|
PENK
|
[NCBI]
|
2.08446e-06
|
|
|
POAG
|
[NCBI]
|
2.07915e-06
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
2.07915e-06
|
|
|
NAT1
|
[NCBI]
|
2.04715e-06
|
|
|
F2
|
[NCBI]
|
2.04715e-06
|
|
|
PSEN2
|
[NCBI]
|
2.04715e-06
|
|
|
DCC
|
[NCBI]
|
2.04715e-06
|
|
|
ABCC2
|
[NCBI]
|
2.02061e-06
|
|
|
UCN
|
[NCBI]
|
1.98279e-06
|
|
|
EPOR
|
[NCBI]
|
1.94933e-06
|
|
|
XPC
|
[NCBI]
|
1.94724e-06
|
|
|
ETV6
|
[NCBI]
|
1.94724e-06
|
|
|
AREG
|
[NCBI]
|
1.94724e-06
|
|
|
HDAC2
|
[NCBI]
|
1.94724e-06
|
|
|
NOS2A
|
[NCBI]
|
1.94724e-06
|
|
|
PLP1
|
[NCBI]
|
1.93887e-06
|
|
|
CPE
|
[NCBI]
|
1.90109e-06
|
|
|
SLC18A2
|
[NCBI]
|
1.83239e-06
|
|
|
KIT
|
[NCBI]
|
1.83239e-06
|
|
|
TFRC
|
[NCBI]
|
1.83239e-06
|
|
|
TRPS2
|
[NCBI]
|
1.81817e-06
|
|
|
melanoma, uveal
|
[NCBI]
|
1.81817e-06
|
|
|
PROK1
|
[NCBI]
|
1.81722e-06
|
|
|
GAD1
|
[NCBI]
|
1.81722e-06
|
|
|
NUMB
|
[NCBI]
|
1.81722e-06
|
|
|
LTK
|
[NCBI]
|
1.81722e-06
|
|
|
TBK1
|
[NCBI]
|
1.81722e-06
|
|
|
GNL3
|
[NCBI]
|
1.81722e-06
|
|
|
BCL2A1
|
[NCBI]
|
1.81722e-06
|
|
|
GOT2
|
[NCBI]
|
1.81722e-06
|
|
|
CX3CL1
|
[NCBI]
|
1.81722e-06
|
|
|
DKK1
|
[NCBI]
|
1.81722e-06
|
|
|
PAX9
|
[NCBI]
|
1.81722e-06
|
|
|
SPTLC1
|
[NCBI]
|
1.81722e-06
|
|
|
TGFB3
|
[NCBI]
|
1.81722e-06
|
|
|
CD55
|
[NCBI]
|
1.81722e-06
|
|
|
FUT3
|
[NCBI]
|
1.81722e-06
|
|
|
RAB7
|
[NCBI]
|
1.81722e-06
|
|
|
TFAP2A
|
[NCBI]
|
1.81722e-06
|
|
|
ALDH3A1
|
[NCBI]
|
1.81722e-06
|
|
|
MAS
|
[NCBI]
|
1.81478e-06
|
|
|
von willebrand disease
|
[NCBI]
|
1.79551e-06
|
|
|
ACVRL1
|
[NCBI]
|
1.76776e-06
|
|
|
TGFBR2
|
[NCBI]
|
1.76776e-06
|
|
|
AQP3
|
[NCBI]
|
1.76776e-06
|
|
|
EDN3
|
[NCBI]
|
1.76776e-06
|
|
|
GCDH
|
[NCBI]
|
1.76776e-06
|
|
|
COL2A1
|
[NCBI]
|
1.76579e-06
|
|
|
RSMD1
|
[NCBI]
|
1.75433e-06
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
1.75433e-06
|
|
|
thyroid hormonogenesis, genetic defect in, 2a
|
[NCBI]
|
1.75433e-06
|
|
|
OPTB3
|
[NCBI]
|
1.75433e-06
|
|
|
NPHS1
|
[NCBI]
|
1.75433e-06
|
|
|
EEC3
|
[NCBI]
|
1.75433e-06
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
1.75433e-06
|
|
|
SCCMS
|
[NCBI]
|
1.75433e-06
|
|
|
hemophilia a
|
[NCBI]
|
1.74868e-06
|
|
|
AHR
|
[NCBI]
|
1.74469e-06
|
|
|
HHF1
|
[NCBI]
|
1.72731e-06
|
|
|
BTHS
|
[NCBI]
|
1.72731e-06
|
|
|
ESD
|
[NCBI]
|
1.72408e-06
|
|
|
SVAS
|
[NCBI]
|
1.71963e-06
|
|
|
porphyria variegata
|
[NCBI]
|
1.71963e-06
|
|
|
CHH
|
[NCBI]
|
1.71963e-06
|
|
|
MCP
|
[NCBI]
|
1.69572e-06
|
|
|
GALT
|
[NCBI]
|
1.62509e-06
|
|
|
RLBP1
|
[NCBI]
|
1.62509e-06
|
|
|
FLNA
|
[NCBI]
|
1.62387e-06
|
|
|
GBA
|
[NCBI]
|
1.60275e-06
|
|
|
ALDH3A2
|
[NCBI]
|
1.60067e-06
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
1.60067e-06
|
|
|
aHUS
|
[NCBI]
|
1.57072e-06
|
|
|
PDS
|
[NCBI]
|
1.57072e-06
|
|
|
mucolipidosis ii
|
[NCBI]
|
1.57072e-06
|
|
|
GH1
|
[NCBI]
|
1.53585e-06
|
|
|
NSEP1
|
[NCBI]
|
1.53168e-06
|
|
|
DLGAP1
|
[NCBI]
|
1.53168e-06
|
|
|
RECK
|
[NCBI]
|
1.53168e-06
|
|
|
PIN1
|
[NCBI]
|
1.53168e-06
|
|
|
ANXA2
|
[NCBI]
|
1.53168e-06
|
|
|
EZH2
|
[NCBI]
|
1.53168e-06
|
|
|
OTX2
|
[NCBI]
|
1.53168e-06
|
|
|
AEBP1
|
[NCBI]
|
1.53168e-06
|
|
|
GNAQ
|
[NCBI]
|
1.53168e-06
|
|
|
STMN1
|
[NCBI]
|
1.53168e-06
|
|
|
SPINK5
|
[NCBI]
|
1.53168e-06
|
|
|
ZNF198
|
[NCBI]
|
1.53168e-06
|
|
|
SCGF
|
[NCBI]
|
1.53168e-06
|
|
|
AQP9
|
[NCBI]
|
1.53168e-06
|
|
|
SELL
|
[NCBI]
|
1.53168e-06
|
|
|
SKP1A
|
[NCBI]
|
1.53168e-06
|
|
|
GADD45A
|
[NCBI]
|
1.53168e-06
|
|
|
CNTFR
|
[NCBI]
|
1.53168e-06
|
|
|
plasmin inhibitor deficiency
|
[NCBI]
|
1.53168e-06
|
|
|
RBPSUH
|
[NCBI]
|
1.53168e-06
|
|
|
ID3
|
[NCBI]
|
1.53168e-06
|
|
|
SEPT9
|
[NCBI]
|
1.53168e-06
|
|
|
SULT1A1
|
[NCBI]
|
1.53168e-06
|
|
|
OLIG2
|
[NCBI]
|
1.53168e-06
|
|
|
XBP1
|
[NCBI]
|
1.53168e-06
|
|
|
ART4
|
[NCBI]
|
1.53168e-06
|
|
|
RIPK1
|
[NCBI]
|
1.52442e-06
|
|
|
CFB
|
[NCBI]
|
1.52442e-06
|
|
|
FH
|
[NCBI]
|
1.52442e-06
|
|
|
SCN5A
|
[NCBI]
|
1.52442e-06
|
|
|
ABCG2
|
[NCBI]
|
1.48471e-06
|
|
|
TERC
|
[NCBI]
|
1.44522e-06
|
|
|
CXCL12
|
[NCBI]
|
1.44522e-06
|
|
|
CFLAR
|
[NCBI]
|
1.44522e-06
|
|
|
isoniazid inactivation
|
[NCBI]
|
1.42582e-06
|
|
|
HS
|
[NCBI]
|
1.42582e-06
|
|
|
TF
|
[NCBI]
|
1.41463e-06
|
|
|
PKD1
|
[NCBI]
|
1.38379e-06
|
|
|
NMB
|
[NCBI]
|
1.36905e-06
|
|
|
LCT
|
[NCBI]
|
1.36905e-06
|
|
|
MNS
|
[NCBI]
|
1.34964e-06
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
1.34964e-06
|
|
|
GABEB
|
[NCBI]
|
1.34964e-06
|
|
|
bladder cancer
|
[NCBI]
|
1.34964e-06
|
|
|
SCN1
|
[NCBI]
|
1.34964e-06
|
|
|
COH1
|
[NCBI]
|
1.33754e-06
|
|
|
FGF2
|
[NCBI]
|
1.33433e-06
|
|
|
NP
|
[NCBI]
|
1.32938e-06
|
|
|
MTAP
|
[NCBI]
|
1.32938e-06
|
|
|
TBG
|
[NCBI]
|
1.32938e-06
|
|
|
NPM1
|
[NCBI]
|
1.31922e-06
|
|
|
POU1F1
|
[NCBI]
|
1.30071e-06
|
|
|
ZFP36
|
[NCBI]
|
1.29419e-06
|
|
|
glycogen storage disease ii
|
[NCBI]
|
1.29218e-06
|
|
|
ATG5
|
[NCBI]
|
1.2844e-06
|
|
|
MPI
|
[NCBI]
|
1.2844e-06
|
|
|
TCL1A
|
[NCBI]
|
1.2844e-06
|
|
|
MTHFD1
|
[NCBI]
|
1.2844e-06
|
|
|
HLA-C
|
[NCBI]
|
1.2844e-06
|
|
|
ATP1A1
|
[NCBI]
|
1.2844e-06
|
|
|
MAT1A
|
[NCBI]
|
1.2844e-06
|
|
|
CDK5R1
|
[NCBI]
|
1.2844e-06
|
|
|
ACAT1
|
[NCBI]
|
1.2844e-06
|
|
|
DUOX2
|
[NCBI]
|
1.2844e-06
|
|
|
CEP290
|
[NCBI]
|
1.2844e-06
|
|
|
NCF2
|
[NCBI]
|
1.2844e-06
|
|
|
GOT1
|
[NCBI]
|
1.2844e-06
|
|
|
HLCS
|
[NCBI]
|
1.2844e-06
|
|
|
COL9A1
|
[NCBI]
|
1.2844e-06
|
|
|
PLAG1
|
[NCBI]
|
1.2844e-06
|
|
|
NCL
|
[NCBI]
|
1.2844e-06
|
|
|
DRD1
|
[NCBI]
|
1.2844e-06
|
|
|
CBP2
|
[NCBI]
|
1.2844e-06
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
1.2844e-06
|
|
|
FANCD2
|
[NCBI]
|
1.2844e-06
|
|
|
AKT1
|
[NCBI]
|
1.23519e-06
|
|
|
NTRK1
|
[NCBI]
|
1.23519e-06
|
|
|
MSTN
|
[NCBI]
|
1.23519e-06
|
|
|
CTSL
|
[NCBI]
|
1.23519e-06
|
|
|
PRF1
|
[NCBI]
|
1.23519e-06
|
|
|
FGF23
|
[NCBI]
|
1.23519e-06
|
|
|
MLL
|
[NCBI]
|
1.23519e-06
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
1.2205e-06
|
|
|
REN
|
[NCBI]
|
1.17988e-06
|
|
|
MTR
|
[NCBI]
|
1.17808e-06
|
|
|
ARNT
|
[NCBI]
|
1.17808e-06
|
|
|
NGFR
|
[NCBI]
|
1.16686e-06
|
|
|
ENPP2
|
[NCBI]
|
1.14333e-06
|
|
|
ALAD
|
[NCBI]
|
1.14333e-06
|
|
|
RNASE2
|
[NCBI]
|
1.13288e-06
|
|
|
HEMB
|
[NCBI]
|
1.12364e-06
|
|
|
GCPS
|
[NCBI]
|
1.11941e-06
|
|
|
MEB
|
[NCBI]
|
1.11941e-06
|
|
|
CLN3
|
[NCBI]
|
1.11941e-06
|
|
|
CMTX1
|
[NCBI]
|
1.11941e-06
|
|
|
kartagener syndrome
|
[NCBI]
|
1.11941e-06
|
|
|
WFS1
|
[NCBI]
|
1.11941e-06
|
|
|
MG
|
[NCBI]
|
1.08563e-06
|
|
|
FUT1
|
[NCBI]
|
1.0699e-06
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
1.0699e-06
|
|
|
CCL18
|
[NCBI]
|
1.0699e-06
|
|
|
SPAM1
|
[NCBI]
|
1.0699e-06
|
|
|
SLC5A1
|
[NCBI]
|
1.0699e-06
|
|
|
SLC27A1
|
[NCBI]
|
1.0699e-06
|
|
|
NDN
|
[NCBI]
|
1.0699e-06
|
|
|
CLDN1
|
[NCBI]
|
1.0699e-06
|
|
|
FOXE1
|
[NCBI]
|
1.0699e-06
|
|
|
ETS2
|
[NCBI]
|
1.0699e-06
|
|
|
TNFRSF6
|
[NCBI]
|
1.0539e-06
|
|
|
STAT5B
|
[NCBI]
|
1.04204e-06
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
1.04204e-06
|
|
|
TNFSF6
|
[NCBI]
|
1.03297e-06
|
|
|
BFLS
|
[NCBI]
|
1.01055e-06
|
|
|
KAL2
|
[NCBI]
|
1.01055e-06
|
|
|
JBS
|
[NCBI]
|
1.01055e-06
|
|
|
LEP
|
[NCBI]
|
9.93575e-07
|
|
|
CDK5
|
[NCBI]
|
9.92401e-07
|
|
|
MAPK14
|
[NCBI]
|
9.67006e-07
|
|
|
VLDLR
|
[NCBI]
|
9.67006e-07
|
|
|
AGER
|
[NCBI]
|
9.58071e-07
|
|
|
INHBA
|
[NCBI]
|
9.26763e-07
|
|
|
RPS6KA3
|
[NCBI]
|
9.26763e-07
|
|
|
NTRK2
|
[NCBI]
|
9.26763e-07
|
|
|
HIGM1
|
[NCBI]
|
9.17206e-07
|
|
|
XLP1
|
[NCBI]
|
9.17206e-07
|
|
|
CADASIL
|
[NCBI]
|
9.17206e-07
|
|
|
IGF1
|
[NCBI]
|
9.04388e-07
|
|
|
MMP9
|
[NCBI]
|
9.04388e-07
|
|
|
MMP7
|
[NCBI]
|
8.83806e-07
|
|
|
UBE1
|
[NCBI]
|
8.83806e-07
|
|
|
GALE
|
[NCBI]
|
8.83806e-07
|
|
|
PKHD1
|
[NCBI]
|
8.83806e-07
|
|
|
ANP32A
|
[NCBI]
|
8.83806e-07
|
|
|
SSTR5
|
[NCBI]
|
8.83806e-07
|
|
|
SIX5
|
[NCBI]
|
8.83806e-07
|
|
|
POMT1
|
[NCBI]
|
8.83806e-07
|
|
|
NAGLU
|
[NCBI]
|
8.83806e-07
|
|
|
ID1
|
[NCBI]
|
8.83806e-07
|
|
|
NTF3
|
[NCBI]
|
8.83806e-07
|
|
|
ME2
|
[NCBI]
|
8.83806e-07
|
|
|
EFNB2
|
[NCBI]
|
8.83806e-07
|
|
|
HEPH
|
[NCBI]
|
8.83806e-07
|
|
|
HSF1
|
[NCBI]
|
8.83806e-07
|
|
|
REST
|
[NCBI]
|
8.82747e-07
|
|
|
GSR
|
[NCBI]
|
8.82747e-07
|
|
|
RUNX1
|
[NCBI]
|
8.82747e-07
|
|
|
IDUA
|
[NCBI]
|
8.79349e-07
|
|
|
TNC
|
[NCBI]
|
8.51549e-07
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
8.32127e-07
|
|
|
LPI
|
[NCBI]
|
8.32127e-07
|
|
|
ADRP
|
[NCBI]
|
8.20186e-07
|
|
|
ALDH2
|
[NCBI]
|
8.20186e-07
|
|
|
RAG1
|
[NCBI]
|
8.20186e-07
|
|
|
menkes disease
|
[NCBI]
|
8.18277e-07
|
|
|
TSHR
|
[NCBI]
|
8.16314e-07
|
|
|
XPA
|
[NCBI]
|
8.14094e-07
|
|
|
RTS
|
[NCBI]
|
8.14094e-07
|
|
|
ENG
|
[NCBI]
|
8.01242e-07
|
|
|
CYP17A1
|
[NCBI]
|
8.01242e-07
|
|
|
USF1
|
[NCBI]
|
8.01242e-07
|
|
|
GJA1
|
[NCBI]
|
7.96292e-07
|
|
|
MAPK1
|
[NCBI]
|
7.95147e-07
|
|
|
G6PD
|
[NCBI]
|
7.89089e-07
|
|
|
SLC18A3
|
[NCBI]
|
7.62769e-07
|
|
|
FGF8
|
[NCBI]
|
7.55139e-07
|
|
|
CMD1A
|
[NCBI]
|
7.31853e-07
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
7.30134e-07
|
|
|
refsum disease, infantile form
|
[NCBI]
|
7.30134e-07
|
|
|
masa syndrome
|
[NCBI]
|
7.30134e-07
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
7.30134e-07
|
|
|
ORW2
|
[NCBI]
|
7.30134e-07
|
|
|
MSS
|
[NCBI]
|
7.30134e-07
|
|
|
polycythemia vera
|
[NCBI]
|
7.30134e-07
|
|
|
HEXB
|
[NCBI]
|
7.22613e-07
|
|
|
GLA
|
[NCBI]
|
7.22613e-07
|
|
|
ADIPOQ
|
[NCBI]
|
7.22613e-07
|
|
|
LPA
|
[NCBI]
|
7.22613e-07
|
|
|
NFKBIA
|
[NCBI]
|
7.2255e-07
|
|
|
FLG
|
[NCBI]
|
7.2255e-07
|
|
|
LAMP2
|
[NCBI]
|
7.2255e-07
|
|
|
ANGPT1
|
[NCBI]
|
7.2255e-07
|
|
|
NCF1
|
[NCBI]
|
7.2255e-07
|
|
|
COL18A1
|
[NCBI]
|
7.2255e-07
|
|
|
EIF2C2
|
[NCBI]
|
7.2255e-07
|
|
|
PPARBP
|
[NCBI]
|
7.2255e-07
|
|
|
FST
|
[NCBI]
|
7.2255e-07
|
|
|
CNR1
|
[NCBI]
|
7.2255e-07
|
|
|
TXN
|
[NCBI]
|
7.2255e-07
|
|
|
COL5A1
|
[NCBI]
|
7.2255e-07
|
|
|
POLD1
|
[NCBI]
|
7.2255e-07
|
|
|
VIL2
|
[NCBI]
|
7.2255e-07
|
|
|
CUL1
|
[NCBI]
|
7.2255e-07
|
|
|
FCGR3A
|
[NCBI]
|
7.2255e-07
|
|
|
RS1
|
[NCBI]
|
7.21857e-07
|
|
|
JAG1
|
[NCBI]
|
7.21857e-07
|
|
|
TPI1
|
[NCBI]
|
7.21857e-07
|
|
|
ABO
|
[NCBI]
|
7.21857e-07
|
|
|
BBS
|
[NCBI]
|
7.15914e-07
|
|
|
FBN1
|
[NCBI]
|
7.09552e-07
|
|
|
MAOA
|
[NCBI]
|
7.09552e-07
|
|
|
MMP2
|
[NCBI]
|
6.72871e-07
|
|
|
CEACAM1
|
[NCBI]
|
6.72871e-07
|
|
|
ARF6
|
[NCBI]
|
6.46989e-07
|
|
|
MMP3
|
[NCBI]
|
6.46989e-07
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
6.45571e-07
|
|
|
DM2
|
[NCBI]
|
6.45571e-07
|
|
|
SRC
|
[NCBI]
|
6.45016e-07
|
|
|
COMT
|
[NCBI]
|
6.42388e-07
|
|
|
GAMT
|
[NCBI]
|
6.31361e-07
|
|
|
C4B
|
[NCBI]
|
6.31361e-07
|
|
|
SI
|
[NCBI]
|
5.97917e-07
|
|
|
LRP1
|
[NCBI]
|
5.95145e-07
|
|
|
FGA
|
[NCBI]
|
5.83262e-07
|
|
|
orotic aciduria i
|
[NCBI]
|
5.83207e-07
|
|
|
KEL
|
[NCBI]
|
5.83207e-07
|
|
|
DLL3
|
[NCBI]
|
5.83207e-07
|
|
|
TAZ
|
[NCBI]
|
5.83207e-07
|
|
|
GCG
|
[NCBI]
|
5.83207e-07
|
|
|
AMFR
|
[NCBI]
|
5.83207e-07
|
|
|
DLL1
|
[NCBI]
|
5.83207e-07
|
|
|
MAN2B1
|
[NCBI]
|
5.83207e-07
|
|
|
CBR1
|
[NCBI]
|
5.83207e-07
|
|
|
CBFA2T1
|
[NCBI]
|
5.83207e-07
|
|
|
SLC16A2
|
[NCBI]
|
5.83207e-07
|
|
|
ANKRD1
|
[NCBI]
|
5.83207e-07
|
|
|
DNMT3A
|
[NCBI]
|
5.83207e-07
|
|
|
CYP11A1
|
[NCBI]
|
5.83207e-07
|
|
|
HGPS
|
[NCBI]
|
5.75478e-07
|
|
|
PDHA1
|
[NCBI]
|
5.74513e-07
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
5.74513e-07
|
|
|
CDA
|
[NCBI]
|
5.74513e-07
|
|
|
HIF1A
|
[NCBI]
|
5.74513e-07
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
5.64375e-07
|
|
|
fucosidosis
|
[NCBI]
|
5.48309e-07
|
|
|
SNRPN
|
[NCBI]
|
5.48309e-07
|
|
|
fabry disease
|
[NCBI]
|
5.4319e-07
|
|
|
BIRC1
|
[NCBI]
|
5.40927e-07
|
|
|
AS
|
[NCBI]
|
5.21287e-07
|
|
|
TNFRSF1A
|
[NCBI]
|
5.15396e-07
|
|
|
SMN2
|
[NCBI]
|
5.05332e-07
|
|
|
TNFRSF1B
|
[NCBI]
|
5.05332e-07
|
|
|
ATP7B
|
[NCBI]
|
5.05332e-07
|
|
|
FY
|
[NCBI]
|
5.05332e-07
|
|
|
CUTL1
|
[NCBI]
|
5.05332e-07
|
|
|
GRN
|
[NCBI]
|
5.05332e-07
|
|
|
NHS
|
[NCBI]
|
5.02523e-07
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
5.02523e-07
|
|
|
ALGS1
|
[NCBI]
|
4.98747e-07
|
|
|
THRB
|
[NCBI]
|
4.78899e-07
|
|
|
LIFR
|
[NCBI]
|
4.72342e-07
|
|
|
GAA
|
[NCBI]
|
4.72342e-07
|
|
|
HP
|
[NCBI]
|
4.68265e-07
|
|
|
KSS
|
[NCBI]
|
4.64276e-07
|
|
|
DEFA1
|
[NCBI]
|
4.6334e-07
|
|
|
SPHK1
|
[NCBI]
|
4.6334e-07
|
|
|
TGFBR1
|
[NCBI]
|
4.6334e-07
|
|
|
TSIX
|
[NCBI]
|
4.6334e-07
|
|
|
ADSL
|
[NCBI]
|
4.6334e-07
|
|
|
ITGB4
|
[NCBI]
|
4.6334e-07
|
|
|
FOXC1
|
[NCBI]
|
4.6334e-07
|
|
|
ALDOA
|
[NCBI]
|
4.6334e-07
|
|
|
HSD17B4
|
[NCBI]
|
4.6334e-07
|
|
|
P4HB
|
[NCBI]
|
4.6334e-07
|
|
|
ANGPT2
|
[NCBI]
|
4.6334e-07
|
|
|
RAF1
|
[NCBI]
|
4.6334e-07
|
|
|
INSR
|
[NCBI]
|
4.40144e-07
|
|
|
SLC1A2
|
[NCBI]
|
4.39608e-07
|
|
|
PDYN
|
[NCBI]
|
4.39608e-07
|
|
|
SGBS1
|
[NCBI]
|
4.15889e-07
|
|
|
DJS
|
[NCBI]
|
4.15889e-07
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
4.03128e-07
|
|
|
HLA-DRA
|
[NCBI]
|
4.03128e-07
|
|
|
SRY
|
[NCBI]
|
3.85759e-07
|
|
|
SCD
|
[NCBI]
|
3.85759e-07
|
|
|
GRIA2
|
[NCBI]
|
3.77513e-07
|
|
|
SHOX
|
[NCBI]
|
3.77513e-07
|
|
|
MICA
|
[NCBI]
|
3.77513e-07
|
|
|
RUNX2
|
[NCBI]
|
3.77513e-07
|
|
|
ADRB2
|
[NCBI]
|
3.77513e-07
|
|
|
HDGF
|
[NCBI]
|
3.77513e-07
|
|
|
PTPRC
|
[NCBI]
|
3.77513e-07
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
3.75842e-07
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
3.73943e-07
|
|
|
FGFR1
|
[NCBI]
|
3.71025e-07
|
|
|
BMP7
|
[NCBI]
|
3.60895e-07
|
|
|
LRP2
|
[NCBI]
|
3.60895e-07
|
|
|
ID2
|
[NCBI]
|
3.60895e-07
|
|
|
KCNJ2
|
[NCBI]
|
3.60895e-07
|
|
|
FRAXE
|
[NCBI]
|
3.60895e-07
|
|
|
LMX1B
|
[NCBI]
|
3.60895e-07
|
|
|
SLC1A1
|
[NCBI]
|
3.60895e-07
|
|
|
PGM3
|
[NCBI]
|
3.60895e-07
|
|
|
DNM1L
|
[NCBI]
|
3.60895e-07
|
|
|
ACACA
|
[NCBI]
|
3.60895e-07
|
|
|
IL9
|
[NCBI]
|
3.60895e-07
|
|
|
XRCC9
|
[NCBI]
|
3.60895e-07
|
|
|
ADRB3
|
[NCBI]
|
3.60895e-07
|
|
|
IRDN
|
[NCBI]
|
3.60895e-07
|
|
|
PCCB
|
[NCBI]
|
3.60895e-07
|
|
|
ECM1
|
[NCBI]
|
3.60895e-07
|
|
|
SOCS1
|
[NCBI]
|
3.40355e-07
|
|
|
MAPK3
|
[NCBI]
|
3.38818e-07
|
|
|
PAX3
|
[NCBI]
|
3.38818e-07
|
|
|
FGF1
|
[NCBI]
|
3.34794e-07
|
|
|
CCL2
|
[NCBI]
|
3.26048e-07
|
|
|
donohue syndrome
|
[NCBI]
|
3.22681e-07
|
|
|
mucolipidosis iv
|
[NCBI]
|
3.22681e-07
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
3.22681e-07
|
|
|
pulmonary fibrosis, idiopathic
|
[NCBI]
|
3.22681e-07
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
3.22681e-07
|
|
|
ACADS
|
[NCBI]
|
3.19235e-07
|
|
|
glycogen storage disease i
|
[NCBI]
|
3.19235e-07
|
|
|
FGG
|
[NCBI]
|
3.19235e-07
|
|
|
FOXO1A
|
[NCBI]
|
3.19235e-07
|
|
|
FANCA
|
[NCBI]
|
3.19235e-07
|
|
|
MTCO1
|
[NCBI]
|
3.19235e-07
|
|
|
FN1
|
[NCBI]
|
3.19235e-07
|
|
|
LAM
|
[NCBI]
|
3.06039e-07
|
|
|
APOD
|
[NCBI]
|
2.96763e-07
|
|
|
TFF3
|
[NCBI]
|
2.96763e-07
|
|
|
REG3A
|
[NCBI]
|
2.96763e-07
|
|
|
OPRM1
|
[NCBI]
|
2.96385e-07
|
|
|
DBA
|
[NCBI]
|
2.84659e-07
|
|
|
SOX9
|
[NCBI]
|
2.83734e-07
|
|
|
CA2
|
[NCBI]
|
2.74128e-07
|
|
|
SN
|
[NCBI]
|
2.74128e-07
|
|
|
PHOX2B
|
[NCBI]
|
2.74128e-07
|
|
|
TMOD
|
[NCBI]
|
2.74128e-07
|
|
|
AMY1A
|
[NCBI]
|
2.74128e-07
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
2.74128e-07
|
|
|
DBT
|
[NCBI]
|
2.74128e-07
|
|
|
CCNE1
|
[NCBI]
|
2.74128e-07
|
|
|
RAG2
|
[NCBI]
|
2.74128e-07
|
|
|
DHCR7
|
[NCBI]
|
2.74128e-07
|
|
|
PHB
|
[NCBI]
|
2.74128e-07
|
|
|
RELA
|
[NCBI]
|
2.74128e-07
|
|
|
CEACAM6
|
[NCBI]
|
2.74128e-07
|
|
|
DLL4
|
[NCBI]
|
2.74128e-07
|
|
|
CMT1B
|
[NCBI]
|
2.66361e-07
|
|
|
neuroblastoma
|
[NCBI]
|
2.66361e-07
|
|
|
AVPR2
|
[NCBI]
|
2.64973e-07
|
|
|
MYO7A
|
[NCBI]
|
2.64973e-07
|
|
|
ACP1
|
[NCBI]
|
2.64973e-07
|
|
|
NR6A1
|
[NCBI]
|
2.64973e-07
|
|
|
coproporphyria
|
[NCBI]
|
2.64973e-07
|
|
|
CDO
|
[NCBI]
|
2.64973e-07
|
|
|
PNMT
|
[NCBI]
|
2.6198e-07
|
|
|
GDNF
|
[NCBI]
|
2.59983e-07
|
|
|
IL10
|
[NCBI]
|
2.4125e-07
|
|
|
DAZ
|
[NCBI]
|
2.32994e-07
|
|
|
KAL1
|
[NCBI]
|
2.32994e-07
|
|
|
tyrosinemia, type i
|
[NCBI]
|
2.32994e-07
|
|
|
MTCO2
|
[NCBI]
|
2.14945e-07
|
|
|
GDF5
|
[NCBI]
|
2.14945e-07
|
|
|
SLAMF1
|
[NCBI]
|
2.14945e-07
|
|
|
ICAM1
|
[NCBI]
|
2.14945e-07
|
|
|
GHRL
|
[NCBI]
|
2.14945e-07
|
|
|
SPP1
|
[NCBI]
|
2.04753e-07
|
|
|
TSC2
|
[NCBI]
|
2.04141e-07
|
|
|
H6PD
|
[NCBI]
|
2.04141e-07
|
|
|
PTGS1
|
[NCBI]
|
2.01544e-07
|
|
|
HSPCA
|
[NCBI]
|
2.01544e-07
|
|
|
HIP1
|
[NCBI]
|
2.01544e-07
|
|
|
ABCC3
|
[NCBI]
|
2.01544e-07
|
|
|
CHRNA1
|
[NCBI]
|
2.01544e-07
|
|
|
MAP4
|
[NCBI]
|
2.01544e-07
|
|
|
RXRA
|
[NCBI]
|
2.01544e-07
|
|
|
DCX
|
[NCBI]
|
2.01544e-07
|
|
|
USF2
|
[NCBI]
|
2.01544e-07
|
|
|
ORM1
|
[NCBI]
|
2.01544e-07
|
|
|
SSTR2
|
[NCBI]
|
2.01544e-07
|
|
|
CPT2
|
[NCBI]
|
2.01544e-07
|
|
|
NTN1
|
[NCBI]
|
2.01544e-07
|
|
|
PI
|
[NCBI]
|
1.88205e-07
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
1.87882e-07
|
|
|
RELN
|
[NCBI]
|
1.87882e-07
|
|
|
MSD
|
[NCBI]
|
1.86262e-07
|
|
|
MLC
|
[NCBI]
|
1.86262e-07
|
|
|
DRD
|
[NCBI]
|
1.86262e-07
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
1.86262e-07
|
|
|
TGFB1
|
[NCBI]
|
1.85463e-07
|
|
|
SOCS3
|
[NCBI]
|
1.85463e-07
|
|
|
NRCLP1
|
[NCBI]
|
1.80918e-07
|
|
|
STL1
|
[NCBI]
|
1.80918e-07
|
|
|
MCOPS7
|
[NCBI]
|
1.80918e-07
|
|
|
HHC1
|
[NCBI]
|
1.80918e-07
|
|
|
PPOX
|
[NCBI]
|
1.69386e-07
|
|
|
ERCC5
|
[NCBI]
|
1.69386e-07
|
|
|
NBS1
|
[NCBI]
|
1.69386e-07
|
|
|
CREM
|
[NCBI]
|
1.69386e-07
|
|
|
CDK6
|
[NCBI]
|
1.69386e-07
|
|
|
ADHD
|
[NCBI]
|
1.63845e-07
|
|
|
FAAH
|
[NCBI]
|
1.55849e-07
|
|
|
SPARC
|
[NCBI]
|
1.53566e-07
|
|
|
L1CAM
|
[NCBI]
|
1.48161e-07
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
1.48161e-07
|
|
|
factor x deficiency
|
[NCBI]
|
1.48161e-07
|
|
|
stomatocytosis i
|
[NCBI]
|
1.45881e-07
|
|
|
SLC5A5
|
[NCBI]
|
1.41852e-07
|
|
|
ASIP
|
[NCBI]
|
1.41852e-07
|
|
|
FOXC2
|
[NCBI]
|
1.41852e-07
|
|
|
FMF
|
[NCBI]
|
1.41403e-07
|
|
|
SLC4A1
|
[NCBI]
|
1.40028e-07
|
|
|
homocystinuria
|
[NCBI]
|
1.34892e-07
|
|
|
EWSR1
|
[NCBI]
|
1.28551e-07
|
|
|
SOX10
|
[NCBI]
|
1.28551e-07
|
|
|
CYBB
|
[NCBI]
|
1.28551e-07
|
|
|
GRPR
|
[NCBI]
|
1.28551e-07
|
|
|
PTN
|
[NCBI]
|
1.28068e-07
|
|
|
BTC
|
[NCBI]
|
1.24402e-07
|
|
|
HBG2
|
[NCBI]
|
1.13609e-07
|
|
|
HHT
|
[NCBI]
|
1.09872e-07
|
|
|
NF2
|
[NCBI]
|
1.09872e-07
|
|
|
LCN2
|
[NCBI]
|
9.80569e-08
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
9.72678e-08
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
9.72678e-08
|
|
|
testicular tumors
|
[NCBI]
|
9.72678e-08
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
9.72678e-08
|
|
|
PAX8
|
[NCBI]
|
9.3931e-08
|
|
|
CTSB
|
[NCBI]
|
9.3931e-08
|
|
|
DLD
|
[NCBI]
|
9.3931e-08
|
|
|
CRIP1
|
[NCBI]
|
9.3931e-08
|
|
|
FOS
|
[NCBI]
|
9.3931e-08
|
|
|
ATR
|
[NCBI]
|
9.3931e-08
|
|
|
HBEGF
|
[NCBI]
|
9.3931e-08
|
|
|
NKX2-1
|
[NCBI]
|
9.3931e-08
|
|
|
CPD
|
[NCBI]
|
9.3931e-08
|
|
|
TCOF1
|
[NCBI]
|
9.3931e-08
|
|
|
GATA3
|
[NCBI]
|
9.3931e-08
|
|
|
NR3C2
|
[NCBI]
|
9.3931e-08
|
|
|
GJB3
|
[NCBI]
|
9.3931e-08
|
|
|
CYP1B1
|
[NCBI]
|
9.3931e-08
|
|
|
EEF2
|
[NCBI]
|
9.3931e-08
|
|
|
EPO
|
[NCBI]
|
9.35733e-08
|
|
|
MARCKS
|
[NCBI]
|
9.27194e-08
|
|
|
oca2 gene
|
[NCBI]
|
9.27194e-08
|
|
|
DYSF
|
[NCBI]
|
9.27194e-08
|
|
|
RECQL3
|
[NCBI]
|
9.27194e-08
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
8.94867e-08
|
|
|
biotinidase deficiency
|
[NCBI]
|
8.94867e-08
|
|
|
hyperglycerolemia
|
[NCBI]
|
8.94867e-08
|
|
|
TFPI
|
[NCBI]
|
8.49982e-08
|
|
|
BPES
|
[NCBI]
|
7.66628e-08
|
|
|
SMN1
|
[NCBI]
|
7.20842e-08
|
|
|
ABCB1
|
[NCBI]
|
6.31845e-08
|
|
|
ERCC2
|
[NCBI]
|
6.21931e-08
|
|
|
FTL
|
[NCBI]
|
6.21931e-08
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
6.21931e-08
|
|
|
SLC40A1
|
[NCBI]
|
6.21931e-08
|
|
|
GNAS
|
[NCBI]
|
6.09587e-08
|
|
|
factor vii deficiency
|
[NCBI]
|
5.9187e-08
|
|
|
HPRT1
|
[NCBI]
|
5.87371e-08
|
|
|
maple syrup urine disease
|
[NCBI]
|
5.81216e-08
|
|
|
HHF2
|
[NCBI]
|
5.81216e-08
|
|
|
IL12A
|
[NCBI]
|
5.67982e-08
|
|
|
MSX1
|
[NCBI]
|
5.67982e-08
|
|
|
MAP2K1
|
[NCBI]
|
5.67982e-08
|
|
|
SLC17A6
|
[NCBI]
|
5.67982e-08
|
|
|
ACOX1
|
[NCBI]
|
5.67982e-08
|
|
|
WBS
|
[NCBI]
|
5.63411e-08
|
|
|
LBP
|
[NCBI]
|
5.52646e-08
|
|
|
AQP4
|
[NCBI]
|
5.41796e-08
|
|
|
PKD2
|
[NCBI]
|
5.41796e-08
|
|
|
WT1
|
[NCBI]
|
5.41796e-08
|
|
|
UGB
|
[NCBI]
|
4.97646e-08
|
|
|
GUSB
|
[NCBI]
|
4.61882e-08
|
|
|
HLA-A
|
[NCBI]
|
4.05784e-08
|
|
|
BTK
|
[NCBI]
|
4.05784e-08
|
|
|
BOR1
|
[NCBI]
|
3.83168e-08
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
3.73491e-08
|
|
|
NPC1
|
[NCBI]
|
3.73491e-08
|
|
|
ADH5
|
[NCBI]
|
3.73044e-08
|
|
|
COL4A5
|
[NCBI]
|
3.73044e-08
|
|
|
APOH
|
[NCBI]
|
3.73044e-08
|
|
|
NCOA3
|
[NCBI]
|
3.73044e-08
|
|
|
DST
|
[NCBI]
|
3.73044e-08
|
|
|
PRODH
|
[NCBI]
|
3.73044e-08
|
|
|
NR1H4
|
[NCBI]
|
3.73044e-08
|
|
|
KCNJ11
|
[NCBI]
|
3.73044e-08
|
|
|
CST3
|
[NCBI]
|
3.73044e-08
|
|
|
E2F1
|
[NCBI]
|
3.73044e-08
|
|
|
PGK1
|
[NCBI]
|
3.68385e-08
|
|
|
ATF3
|
[NCBI]
|
3.68385e-08
|
|
|
MTTL1
|
[NCBI]
|
3.46372e-08
|
|
|
BGLAP
|
[NCBI]
|
2.96696e-08
|
|
|
MIP
|
[NCBI]
|
2.95902e-08
|
|
|
RPS19
|
[NCBI]
|
2.95902e-08
|
|
|
GSK3B
|
[NCBI]
|
2.95902e-08
|
|
|
FKRP
|
[NCBI]
|
2.95902e-08
|
|
|
AQP5
|
[NCBI]
|
2.95902e-08
|
|
|
MTCO3
|
[NCBI]
|
2.95902e-08
|
|
|
NKX2E
|
[NCBI]
|
2.95902e-08
|
|
|
CFNS
|
[NCBI]
|
2.90505e-08
|
|
|
ODDD
|
[NCBI]
|
2.90505e-08
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
2.90505e-08
|
|
|
gaucher disease, type iii
|
[NCBI]
|
2.90505e-08
|
|
|
NEM3
|
[NCBI]
|
2.90505e-08
|
|
|
PPARG
|
[NCBI]
|
2.37328e-08
|
|
|
IGHG1
|
[NCBI]
|
2.30889e-08
|
|
|
CHUK
|
[NCBI]
|
1.84169e-08
|
|
|
CAV1
|
[NCBI]
|
1.84169e-08
|
|
|
ADK
|
[NCBI]
|
1.84169e-08
|
|
|
DHH
|
[NCBI]
|
1.84169e-08
|
|
|
PLD2
|
[NCBI]
|
1.84169e-08
|
|
|
NCOA2
|
[NCBI]
|
1.84169e-08
|
|
|
MAFD2
|
[NCBI]
|
1.69172e-08
|
|
|
HRG
|
[NCBI]
|
1.27909e-08
|
|
|
CD59
|
[NCBI]
|
1.15431e-08
|
|
|
LDHB
|
[NCBI]
|
1.15431e-08
|
|
|
MTM1
|
[NCBI]
|
1.15431e-08
|
|
|
HPX
|
[NCBI]
|
1.15431e-08
|
|
|
PAX2
|
[NCBI]
|
1.15431e-08
|
|
|
BMP15
|
[NCBI]
|
1.15431e-08
|
|
|
CDKN1C
|
[NCBI]
|
1.15431e-08
|
|
|
MAPK7
|
[NCBI]
|
1.15431e-08
|
|
|
HMGB1
|
[NCBI]
|
1.14808e-08
|
|
|
UNG
|
[NCBI]
|
1.14808e-08
|
|
|
PLG
|
[NCBI]
|
8.25952e-09
|
|
|
LFNG
|
[NCBI]
|
5.93102e-09
|
|
|
SLC25A4
|
[NCBI]
|
5.93102e-09
|
|
|
SMPD1
|
[NCBI]
|
5.93102e-09
|
|
|
THRA
|
[NCBI]
|
5.93102e-09
|
|
|
SLC22A6
|
[NCBI]
|
5.93102e-09
|
|
|
TFF1
|
[NCBI]
|
5.93102e-09
|
|
|
HBFQTL1
|
[NCBI]
|
5.89514e-09
|
|
|
RCDP1
|
[NCBI]
|
5.89514e-09
|
|
|
OPTB1
|
[NCBI]
|
5.89514e-09
|
|
|
OKS
|
[NCBI]
|
5.89514e-09
|
|
|
DFFB
|
[NCBI]
|
4.45032e-09
|
|
|
GNRHR
|
[NCBI]
|
4.45032e-09
|
|
|
FGF7
|
[NCBI]
|
4.02442e-09
|
|
|
LHCGR
|
[NCBI]
|
3.95622e-09
|
|
|
PTH
|
[NCBI]
|
3.48722e-09
|
|
|
DYX1
|
[NCBI]
|
2.0442e-09
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
2.0442e-09
|
|
|
lung cancer
|
[NCBI]
|
2.0442e-09
|
|
|
PPARGC1A
|
[NCBI]
|
1.97788e-09
|
|
|
CDC42
|
[NCBI]
|
1.97788e-09
|
|
|
ALDH1A1
|
[NCBI]
|
1.97788e-09
|
|
|
GJA5
|
[NCBI]
|
1.97788e-09
|
|
|
CTSK
|
[NCBI]
|
1.97788e-09
|
|
|
GSTM1
|
[NCBI]
|
1.97788e-09
|
|
|
CLU
|
[NCBI]
|
8.65175e-10
|
|
|
FRDA
|
[NCBI]
|
8.32641e-10
|
|
|
A2M
|
[NCBI]
|
5.76715e-10
|
|
|
PGM1
|
[NCBI]
|
5.76715e-10
|
|
|
PARG
|
[NCBI]
|
5.76715e-10
|
|
|
MTM1
|
[NCBI]
|
5.23413e-10
|
|
|
IVD
|
[NCBI]
|
2.88323e-10
|
|
|
PROP1
|
[NCBI]
|
2.88323e-10
|
|
|
GPX1
|
[NCBI]
|
2.88323e-10
|
|
|
MUT
|
[NCBI]
|
2.88323e-10
|
|
|
ITGA2B
|
[NCBI]
|
2.88323e-10
|
|
|
ALB
|
[NCBI]
|
9.79978e-11
|
|
|
CGD
|
[NCBI]
|
5.29554e-11
|
|